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TIIVISTELMÄ
Tämä tutkimus on osa Kansanterveyslaitoksen Mielenterveyden ja Alkoholitutkimuksen
osaston ja Helsingin ja Uudenmaan sairaanhoitopiirin Peijaksen sairaalan Psykiatrian tulos-
yksikön vakavan masennustilan etenevää tutkimusta (Vantaa Depression Study), jossa
seurataan 269 ajankohtaisesta vakavasta masennustilasta kärsivää psykiatrisen erikoissai-
raanhoidon avohoito- ja sairaalapotilasta.
806 aikuispotilasta, iältään 20-59v, seulottiin depressiivisten oireiden osalta ja 542 haasta-
teltiin puolistrukturoidulla haastattelumenetelmällä (SCAN). Tutkimukseen valikoitui 269
potilasta (miehiä 72, naisia 197), jotka täyttivät ajankohtaisen vakavan masennustilan oire-
kriteerit. Heidät haastateltiin puolistrukturoiduin haastattelumenetelmin myös muiden
psykiatristen häiriöiden poissulkemiseksi. Poissulkukriteereinä olivat kaksisuuntainen
mielialahäiriö (tyyppi I ja II), skitsofrenia ja muut psykoosit, skitsoaffektiivinen häiriö sekä
orgaaninen tai kemiallisen aineen aiheuttama mielialahäiriö. 6 kk ja 18 kk seurantavaiheissa
potilaat haastateltiin uudelleen vastaavin menetelmin kuin sisäänottovaiheessa. Itsetuho-
käyttäytymistä kartoitettiin sekä tutkimukseen sisäänotto- että tutkimuksen seurantavaiheissa
psykometrisellä kyselykaavakkeella (Scale for Suicidal Ideation), haastattelukysymyksin ja
sairauskertomustietojen perusteella. Niitä potilaita, jotka sisääntulovaiheessa arvioitiin itse-
tuhoisiksi (potilaat, joilla esiintyi voimakkaita mielen täyttäviä itsemurha-ajatuksia), seurat-
tiin viikottain itsemurha-ajatusten, masennusoireiden, toivottomuuden ja ahdistuneisuuden
suhteen.
Tässä tutkimuksessa todettiin itsemurha-ajatusten olevan varsin yleistä masennuspotilaiden
joukossa. Lähes 60%:lla masennuspotilaista todettiin itsemurha-ajatuksia ja 15% potilaista
oli yrittänyt itsemurhaa sisäänottovaiheessa. Potilaiden, joilla esiintyi itsemurha-ajatuksia
tai jotka olivat yrittäneet itsemurhaa, yleinen oiretaso oli vakavampaa kuin niillä masennus-
potilailla, joilla ei esiintynyt itsemurha-alttiutta.
Seuranta-aikana 8% potilaista yritti itsemurhaa vähintään kerran. Riski itsemurhayritykselle
oli selvästi suurempi masennusepisodin aikana verrattuna remissiojaksoon (masennuksen
elpymisvaiheeseen). Seurannan aikana tapahtuvaa itsemurhayritystä ennustivat parisuhteen
puuttuminen, aikaisemmat itsemurhayritykset ja masennusjakson pituus.
8Itsemurha-ajatukset lievittyivät suurimmalla osalla potilaista 2-3 kuukauden kuluessa. Niillä
masennuspotilailla, joiden yleinen oiretaso oli vakavampi seurannan alussa, itsemurha-aja-
tukset myös kestivät kauemmin. Sekä depressio-oireiden että toivottomuuden tason lievitty-
minen edelsi itsemurha-ajatusten laskua. On mahdolista, että molemmilla, sekä depressio-
oireiden että toivottomuuden lievittymisellä, on näinollen kausaalinen rooli itsetuhoisen
prosessin suunnanmuutoksessa. Täten masennuksen hyvä hoito näyttäisi olevan tehokas
keino myös itsemurhien ennaltaehkäisemisessä.
Itsetuhoiset potilaat, eli kaikki ne potilaat, joilla esiintyi vakavia itsemurha-ajatuksia tai ne,
jotka olivat yrittäneet itsemurhaa (joko yhden tai useamman kerran), saivat useammin
lääkehoitoa ja heillä oli tiiviimpi hoitokontakti psykiatriseen erikoissairaanhoitoon kuin
masennuspotilailla, joilla ei esiintynyt itsetuhokayttäytymistä. Myös heidän asenteensa anti-
depressiiviseen lääkitykseen oli suotuisampi ja kiinnittyminen hoitoon yhtä hyvä kuin muil-
lakin masennuspotilailla.
Vaikka itsetuhoiset masennuspotilaat tiedetään moniongelmaisiksi, tämä tutkimus ei tue sitä
käsitystä, että heidän asenteensa hoitoon tai sen jatkuvuuteen olisi heikompi kuin masen-
nuspotilailla, joilla ei esiinny itsetuhokäyttäytymistä. Ongelmat, jotka liittyvät hoidon jatku-
vuuteen näyttäisivät olevan yhteisiä kaikille psykiatrisille potilaille.
Avainsanat: depressio, itsemurha-ajatukset, itsemurhayritys
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ABSTRACT
This study is part of an ongoing collaborative research and development project, the
Vantaa Depression Study (VDS), between the department of Mental Health and Alcohol
Research of the National Public Health Institute, Helsinki and the Department of
Psychiatry of Helsinki University Hospital (HUCH), Peijas hospital (the Peijas Medical
Care District, PMCD), Vantaa. The VDS is a prospective, naturalistic cohort study of 269
secondary-level care psychiatric out- and inpatients with a new episode of Diagnostic and
Statistical Manual of Mental Disorders, 4th edition (DSM-IV) major depressive disorder
(MDD).
VDS involved 806 adult patients (aged 20-59 years), who were screened for a possible new
episode of DSM-IV MDD. 542 consenting patients were interviewed with a semistructured
interview [the WHO Schedule for Clinical Assessment in Neuropsychiatry (SCAN), Version
2.0]. 269 patients (Nmales=72, Nfemales=197) with a current DSM-IV MDD were included in
the study. Further they were interviewed with semistructured interviews to assess all
other psychiatric diagnoses. Exclusion criteria were DSM-IV bipolar disease I and II,
schizophrenia and other non-affective psychoses, schizoaffective disorder, organic and
substance-induced mood disorders. At 6- and 18-month follow-up the interviews were
repeated. Suicidal behaviour was investigated both at intake and follow-up by using a
psychometric scale (Scale for Suicidal Ideation) and interviewer’s questions as well as
the patient’s psychiatric records. Patients, who reported suicidal ideation while entering
the study were followed up weekly, and their level of suicidal ideation, hopelessness,
anxiety and depression was measured.
In this study suicidal ideation (i.e. thoughts serving the agent of one’s own death) was
common among psychiatric patients with MDD. Almost 60% of the depressed patients reported
suicidal ideation and 15% of patients attempted suicide at the baseline. Patients with
suicidal ideation or attempts had a clearly higher level of overall psychopathology than
non-suicidal patients.
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During the 18-month follow-up period 8% of patients attempted suicide. The risk of an
attempt was markedly higher (RR=7.54) during an episode of major depression compared with
a period of remission. Suicide attempt during the follow-up period was predicted by lack
of partner, a history of previous suicide attempts and time spent in depression.
Suicidal ideation resolved for most of the suicidal patients during the first 2 to 3
months. The duration of suicidal ideation was longer for patients with an initially higher
level of psychopathology. Declines both in depression and hopelessness independently
predicted the subsequent decline in suicidal ideation. They both could have a causal role
in reversing the suicidal process. Thus effective treatment of depression is a credible
measure in suicide prevention.
Patients with suicidal behaviour often received more antidepressants and had more frequent
appointments with mental health professionals than non-suicidal patients. Suicidal
patients had also more favourable attitudes towards antidepressant treatment and
comparable adherence to treatment than those not suicidal.
Although we know that problems of suicidal patients comprise several different domains,
this study does not support the conception that patient attitudes or adherence to
treatments would be a factor differentiating suicidal patients from non-suicidal. Instead,
problems with adherence or attitudes seem to be generic to all psychiatric care.
Keywords: depression, suicidal ideation, suicide attempt.
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CBT             Cognitive-Behavioural Therapies
CSF             Cerebrospinal fluid
DA              Dopamine
DALY            Disability adjusted life years
DAT             Differential Activation Theory
DSM-IV          Diagnostic and Statistical Manual of Mental Disorders, 4th edition
DST             Dexamethasone Suppression Test
EDA             Electrodermal Activity
ECA             Epidemiological Catchment Area Study
ECT             Electroconvulsive therapy
FINHCS          Finnish Health Care Survey
GAD             Generalized Anxiety Disorder
HAM-D           Hamilton Rating Scale for Depression
HR              Hazard Ratio
HS              Beck Hopelessness Scale
5-HTP           5-hydroxy-tryptophan
5HTT            Serotonin transporter gene
HUCH            Helsinki University Central Hospital
HVA             Homovanillinic acid
ICD-10          International Classification of Diseases, 10th edition
IPT             Interpersonal Psychotherapy
IRLE            Interview for Recent Life Events
LIFE            Longitudinal Interval Follow-up Evaluation
NESARC          National Epidemiologic Survey on Alcohol and Related Conditions
MAO             Monoamine Oxidase
MDD             Major Depressive Disorder
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SA              Suicide Attempt
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SCAN            Schedules for Clinical Assessment of Neuropsychiatry
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SPSS            Statistical Package for the Social Sciences for Windows
SSI             Scale for Suicidal Ideation
TH              Tyrosine Hydroxylase
TPH             Tryptophan Hydroxylase
VDS             Vantaa Depression Study
WHO             World Health Organization
YLD             Years lost due to disability
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1   INTRODUCTION
Approximately one million people worldwide commit suicide annually. Every 40 seconds a
person commits suicide somewhere in the world. The number of lives lost each year through
suicide exceeds the number of deaths due to homicide and war combined. Suicidal behaviour
has become a major public health problem throughout the world. Suicide is one of the
leading causes of death in the world, especially in Western countries and among young
adults it is the leading cause, this is also the case in Finland. It is estimated that
every suicide has serious impact on at least six other people and the psychological,
social and financial impact of suicide on the family and community is immeasurable.
Suicidal behaviour – suicidal ideation, suicide attempt and completed suicide – probably
represents a continuum of self-harming behaviours. Suicidal behaviour as a concept
includes the tendency, thoughts or acts of self-harming behaviour or life-threatening
risks. Suicidal behaviour can be direct – suicidal ideation, suicide attempt or completed
suicide, or indirect – such as risky driving, high-risk hobbies, hazardous alcohol
drinking, drug misuse or neglecting the management of physical illness. Acute suicidal
behaviour can be an escape from an unbearable situation or state of mind, while chronic
suicidal behaviour can be seen as a part of person’s life story, emerging as a possible
solution in times of crises. When looking at the prevalence of different types of suicidal
behaviour, prevalence of completed suicide presents only the tip of the iceberg. Non-fatal
suicidal behaviour – suicidal ideation and suicide attempts are far more common,
especially among young people. The number of suicide attempts may be up to 20 times or
more than the number of completed suicides.
Attempted suicide or deliberate self-harm is common, often repeated and denotes a risk of
subsequent suicide. It represents considerable psychological distress and it is often
linked to long-standing adversity and acute life-events.
Studies on suicide and suicidal behaviour have revealed that suicide is a multifactorial
act. Since Durkheim (1897) the importance of social factors, stressors, familial factors
etc. have been recognized. The majority of people who commit suicide have a diagnosable
mental disorder and suicidal behaviour is more frequent in psychiatric patients. Suffering
from any mental disorder has been associated with a significantly elevated risk of
premature death. Depression is the most common mental disorder in completed suicide and
also one of the most important risk factors for all suicidal behaviour. Other common
diagnostic categories among people completing suicide are personality disorders and
substance use disorders (Henriksson et al., 1993).
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Major depressive disorder (MDD) is a highly prevalent, aetilogically multifactorial and
clinically heterogenous disorder. It is also one of the most important mental disorders in
terms of public health impact. According to WHO assessed Global Burden of Disease
analysis, unipolar depressive disorders are ranked as the fourth leading cause of burden
among all diseases and the leading cause of years lost due to disability (YLDs) in the
year 2000. While the estimates demonstrate the current high level of burden resulting from
depressive disorders, the outlook for the future is worse. If current trends for
demographic and epidemiological transition continue, the burden of depression will
increase and by the year 2020 depression will become the second leading cause of
disability adjusted life years (DALYs) lost. Worldwide it will be second only to ischaemic
heart disease and in the developed regions depression will be the highest ranking cause of
burden of disease (Murray & Lopez, 1996). Depression can affect individuals at any stage
of the life span. It is essentially an episodic recurring disorder. Epidemiological
studies show that treatment for depression is often inadequate or depression is
unrecognized. Depression appears to be a chronic illness with a high risk of recurrence
over one’s lifetime, especially when adequate treatment is not available. Substantial
numbers of depressive patients end their lives by committing suicide. Suicide remains one
of the most common outcome of depression.
The association between suicidal behaviour and MDD is well known. Studies have usually
focused on completed suicide and MDD, but it is essentially important to study non-fatal
suicidal behaviour in MDD. This gives us more comprehensive information concerning the
prevention of suicides.
The Vantaa Depression Study (VDS) is a prospective, naturalistic, research and development
study of 269 secondary-level care psychiatric out- and inpatients with a new episode of
Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) MDD. In the
VDS the predictors of chronicity, recurrences, suicidal behaviour as well as functional
and work disability are investigated and the adequacy of treatment evaluated. The present
thesis focuses on suicidal behaviour among depressive patients followed up for 18 months.
16
2   REVIEW OF THE LITERATURE
2.1 Classification of suicidal behaviour
Suicidal behaviour as a concept includes the tendency, thoughts or acts of self-harming
behaviour or life threatening risks. Currently suicidal behaviour is characterized with a
broad variety of terminology in the literature of suicide research. We have the American
Psychiatric Association (APA) definitions of terms in use (American Psychiatric
Association, 2003), but there is no generally accepted classification of suicidal
behaviours, and this can also be a source of some confusion (for example: attempted
suicide – self harm – parasuicide). Suicidal behaviour can vary with respect to
manifestation, permanence, seriousness and lethality.
During the past decades there has been debate whether those attempting suicide and those
completing, present a single or two separate populations (Linehan, 1986; Beautrais, 2001).
It seems that they are overlapping populations. The three types of suicidal behaviour –
suicidal ideation, suicide attempt and completed suicide, can be seen as a continuum of
self-harming behaviours (Beck et al. 1973).
2.2 The multifactorial aetiology of suicidal behaviour
Several arguments suggest that suicidal behaviour is an independent disorder, although
psychiatric disturbances are major contributing factors. More than 90% of suicide victims
and most of the attempters, as well ideators have a psychiatric disorder (Robins et al.,
1959; Dorpat & Ripley, 1960; Barraclough et al., 1974; Rich et al., 1988; Henriksson et
al., 1993; Zimmerman et al., 1995; Beautrais et al., 1996; Mann, 2002; 2005).
However, although the presence of a psychopathology is a strong predictor for suicide,
even in the psychiatric groups at the highest risk, only a minority of people with these
diagnoses attempt or commit suicide, indicating the importance of a diathesis or
predisposition to suicidal behaviour that is independent of the main psychiatric disorders
(Mann, 2003; Turecki, 2005).
Traditionally, risk factors for suicidal behaviour have been divided into medical (e.g.
mental disorders), psychosocial (e.g. divorce), cultural (e.g. lack of religious
commitment) and socio economic (e.g. unemployment). Recently, the risk factors behind
suicidal behaviour were also categorized into three main groups: genetic and environmental
factors and interaction between these two (Marusic & Farmer, 2001).
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2.2.1 Familial and genetic factors in suicidal behaviour
Studies analyzing family, twins and adoption have been concordant in suggesting the
implication of genetic factors in suicidal behaviour. Persons who attempt or commit
suicide, have a significantly increased rate of suicidal acts in their families (Roy,
1983; Linkowski et al., 1985; Pfeffer et al., 1994). Twin studies as well as adoption
studies have also shown a high concordance in the rates for completed suicides and suicide
attempts (Schulsinger et al., 1979; Roy et al., 1991; 1995; Statham et al., 1998; Brent &
Mann, 2005). For example, the concordance of suicide for identical twins is 11.5% and for
fraternal twins 2% (Roy et al., 1991). The heritability of suicidal behaviour, especially
suicide, is comparable to the heritability of other major psychiatric disorders, such as
bipolar disorder and schizophrenia. It is estimated that 43% of the variability in
suicidal behaviour may be explained by genetics, while the remaining 57% may be explained
by environmental factors (Roy, 1993a; Roy et al., 1995; McGuffin et al., 2001; Mann,
2002).
2.2.2 Neurobiology of suicidal behaviour
Different neurotransmitter systems have been the most researched area in the field of
neurobiology of suicidal behaviour. Post-mortem brain analyses have provided us a lot of
valuable data on the serotonergic, noradrenergic and dopaminergic neurotransmitter systems
and the cellular morphology of suicide victims. Studies have shown that altered
serotonergic function is associated with the diathesis for suicidal behaviour (Mann et
al., 1998). Serotonergic abnormalities are related to many psychopathological dimensions
such as anxiety, depressed mood, impulsivity and aggression. Post-mortem brain receptor
mapping studies suggest that reduced serotonergic input to the orbital prefrontal cortex,
hypothalamus, occipital cortex and brainstem may be deficient in persons who are at risk
of suicidal behaviour and may underlie a general propensity for aggressive and impulsive
behaviours (Arango et al., 1995; Mann et al., 1996; 2000). Serotonergic hypofunction
appears to be associated with more lethal suicidal behaviour (Mann et al., 1992; Malone et
al., 1996). This abnormality could be localized to the ventromedial prefrontal cortex
(Arango et al., 1995). Alterations were observed on the receptor level, as postsynaptic
5-HT1A and 5-HT2A receptors were found to be upregulated in prefrontal cortex and this
increase was suggested as being a compensatory mechanism to the low activity of the
serontonergic neurons (Mann, 2003). 5-HT1A upregulation seems to be localized to the
ventral prefrontal cortex, a region that is involved in behavioural and cognitive
inhibition, and low serotonergic input may contribute to impaired inhibition, creating a
greater propensity to act upon suicidal or aggressive feelings (Arango et al., 1995; Mann,
2003).
These findings are underlined by investigation with fenfluramine. Malone et al. (1996)
found that fenfluramine induced an increase in prolactin secretion in healthy people, but
in suicide attempters with a higher degree of lethality, the increase was more blunted.
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Only few post-mortem studies covered alterations of the noradrenergic or dopaminergic
systems. The main findings were decreased noradrenalin (NA) levels in the brainstem and
increased alpha2-adrenergic receptor densities, suggested as being upregulated due to the
NA deficit (Ordway et al., 1994a). The results with tyrosine hydroxylase (TH) were
divergent, as both increased (Ordway et al., 1994b) and decreased immunoreactivity were
observed (Biegon & Fieldus, 1992). For dopaminergic system no alterations were found
(Sumiyoshi et al., 1995; Hurd et al., 1997). In a recent study, the cerebrospinal fluid
(CSF) of depressed suicide attempters demonstrated reduced homovanillinic acid (HVA)
levels, but not in depressed non-attempters, thus suggesting a relation of dopamine (DA)
to suicide but not to depression (Sher et al., 2006).
The specific genes that contribute to suicide risk independently of associated psychiatric
disorders are unknown. On the basis of the neurobiological findings, genetic studies have
been carried out in order to elucidate the genetic contribution to the vulnerability of
suicidal behaviour. As there is convincing evidence that a serotonergic dysfunction is
involved in the biological susceptibility to suicide, the majority of studies are focusing
with genes of the serotonin pathway as possible candidates (Bondy et al., 2006).
As it is believed that the variability of serotonergic neurotransmitters plays a pivotal
role in individual differences on mood, impulsiveness and aggression, it is no surprise
that molecular genetic studies of suicide and suicidal behaviour focus on serotonergic
genes. Genes related to the serotonergic system are candidate genes worthy of study as
part of the genetic diathesis for suicidal behaviour. These candidate genes can be
classified into three subgroups:
1. Gene involved in synthesis of serotonin (tryptophan hydroxylase – TPH).
2. Genes involved in serotonergic neurotransmission (serotonin transporter – 5HTT).
   5HTT regulates re-uptake of serotonin into pre-synaptic neuron and different
   serotonin receptors that also regulate neurotransmission.
3. Genes involved in serotonin catabolism (monoamine oxidase – MAO).
TPH is the rate-limiting enzyme in serotonin (5-HT) biosynthesis, converting the
amino-acid tryptophan to 5-hydroxy-tryptophan (5HTP), which is further decarboxylated into
5-HT. TPH gene was among the first candidate genes for association studies of suicidality.
Two different TPH isoforms (TPH1 and TPH2) have been identified.
There are several studies focusing on TPH1 polymorphism in the frame of depressed,
bipolar, schizophrenic or alcoholic patients. Although the numbers of patients within the
diagnostic categories seemed to be sufficient, the number of those with suicidal attempts
was small in most studies. Three recent meta-analyses pooled results from individual
studies in order to test whether TPH1 polymorphisms affect the vulnerability for suicidal
behaviour (Lalovic & Turecki, 2002; Rujescu et al., 2003; Belliver et al., 2004). In their
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combined results Lalovic and Turecki (2002) found no association between suicidal
behaviour and TPH1 polymorphism. Rujescu et al. (2003) found a weak, but yet highly
significant association, which Belliver et al. (2004) could replicate by a further, more
refined meta-analysis. However, the positive results found in some studies (Mann et al.,
1997; Souery et al., 2001; Abbar et al., 2001; Turecki et al., 2001), could not be
replicated in all studies and the list of negative findings is long. The impact of the
TPH1 gene on suicidal behaviour remains still ambiguous because of discrepancy of the
results together with the small number of patients, the diagnostic heterogeneity with
either committed suicide or a history of suicidal attempts, and finally because of the use
of different markers. The identification of the brain-specific, second isoform TPH2 gene,
promised to be a step forward in investigating the genetic contribution to suicidality, as
this isoform apparently plays a more important role in the synthesis of brain serotonin
and thus may be a better candidate gene. However, the number of studies using the TPH2 as
the candidate gene is small (Zill et al., 2004; Kennedy et al., 2003; De Luca et al.,
2005; Zhou et al., 2005). The results so far are promising, although the functional
consequences of these polymorphisms are unknown and the data on TPH2 gene are somewhat
limited.
The serotonin transporter (5-HTT) has two allelic variants: long and short. The short form
was hypothesized to be associated with impulsive aggression and suicidal behaviour (Mann
et al., 2000). Some studies found an association between the short form and violent
suicidal behaviour but, also in contrast to these positive findings, a variety of studies
did not observe any association to suicidal behaviour. Despite the many discrepant results
there is still an ongoing interest on genetic variants of 5-HTT as the possible indicator
of suicidality (Bondy et al., 2006).
Studies focusing on serotonin receptors (5-HT2A, 5-HT1A) or on genes involved in serotonin
catabolism (tyrosine hydroxylase, monoamine oxidase A) have been interesting, but the
results so far have mostly not been convincing (Bondy et al., 2006).
The association of low concentrations of 5-hydroxyindoleatic acid (5-HIAA) in the CSF and
suicidal behaviour was first reported by Åsberg et al. (1976) and since that replicated in
several studies (Mann, 2003; Samuelsson et al., 2006). Also electrodermal activity (EDA)
(Wolfersdorf & Straub, 1994) and β-adrenergic receptor binding (Little et al., 1993) have
been investigated, but the findings have been not consistent. Non-suppression on the
dexamethasone suppression test (DST) in depression has been found to be associated with
suicidal behaviour, especially completed suicide. The relationship between attempted
suicide and DST has been less consistent (Yerevanian et al., 2004).
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2.2.3 Psychological background of suicidal behaviour
Early cognitive accounts of suicidal behaviour were developed from cognitive theories of
depression (Beck & Greenberg, 1971; Beck et al., 1975). Suicidal patients were assumed to
share the frequent occurence of depressed patients’ negative thinking, compounded by
logical errors, and a tendency for long-term belief structures to be activated by current
depression. Freud proposed in the influential 1917 paper, Mourning and Melancholia, that
most individuals cope with the loss of a loved person through the experience of mourning.
However, he believed that there are other vulnerable individuals for whom the loss
experience is unbearable and generates enormous anger. The individual feels ambivalence
but preserves the mental image of the loved one by internalization and it becomes part of
the ego. Feelings of anger towards the lost objective are not possible to express and so
they are transformed into self-sensure and the wish to harm oneself. When these feelings
reach a critical pitch, they lead to the urge to destroy the self. Beck with his
colleagues (1975; 1990) showed in their research that there is a strong relationship
between life stress and suicidal behaviour. When depressed patients believe that there is
no solution to their problems, they consider suicide as a way out of an intolerable and
hopeless situation. Hopelessness as it occurs in depressed patients may be viewed as
characteristics related to both state and trait. During depression, hopelessness escalates
and then subsides over the course of illness. Cognitive research on suicide and risk
prediction has developed a model of suicidal behaviour in which hopelessness is a key
psychological variable. Hopelessness has been found to play a major role in suicidal
behaviour, and in many cases hopelessness has proven to be a better predictor of suicidal
intent than depression, and is believed to mediate the relationship between depression and
suicidal behaviour. Further research emphasized the widespread impairment of interpersonal
problem solving in suicidal patients. Among the variables studied in suicidal patients,
depression, hopelessness and problem solving have become a recurrent theme.
Suicidal ideation arises as a symptom of depression, especially if there are reasons for a
person to feel hopelessness with regard to the future. Still, the majority of individuals
who experience suicidal ideation do not attempt suicide (Kessler et al., 1999). It is
important to explain how or why suicidal ideation arises and why it is maintained and
exacerbated to the point of a possible suicide attempt. Ringel introduced the concept of
the Presuicidal Syndrome which has three principal components: constriction, inhibited
aggression turned toward the self and suicidal fantasies. The Presuicidal Syndrome relates
to specific psychic state of mind that can lead to suicidal acts. It is proposed that the
Presuicidal Syndrome provides a basis for better judgement of the danger of suicide and
makes more focused suicide prevention possible (Ringel, 1976). Williams et al. (2001)
suggested recently that suicidal ideation and behaviour arise from feelings of entrapment,
that there is no escape, and that this represents a particular pattern of information
processing concerning one’s self and the world. Suicidal ideation can last only a short
while if one can think of other, alternative ways to solve problems. Impairment in problem
solving reduces this capacity. Suicidal feelings may alleviate if the person feels that he
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or  she  has  something  to  look  forward  in  the  future, some  important reasons  for living.
Hopelessness with regard to the future takes away these possibilities. The combination of
a poor problem-solving capacity and hopelessness has become the main object of research
interested in psychological process.
2.2.3.1 Stress – diathesis model of suicidal behaviour
Although suicidal behaviour is episodic, occurring most often when a person is in an
episode of depression and not when they are in remission, not all people who suffer from
recurrent depression become suicidal, and some suicidal behaviour occurs in individuals
who are not clinically depressed. Thus, a psychiatric disorder is generally a necessary,
but insufficient condition for suicide. Mann et al. (1999) proposed a stress-diathesis
model in which the risk for suicidal acts is not determined merely by a psychiatric
illness (the stressor) but also by a diathesis (Figure 1). They wanted to develop a model
to help determine who remains vulnerable, despite seeming to have recovered, and how this
underlying vulnerability relates to the acute suicidal state. The diathesis may be
reflected in the tendencies to experience more suicidal ideation and to be more impulsive
and thus being more likely to act on suicidal feelings. In their study Mann et al. (1999)
found that a trait factor, such as aggression/impulsivity, was significant in
distinguishing past suicide attempters from non-attempters. This categorized individuals
at risk from suicide attempts regardless of psychiatric diagnosis. Their model showed that
subjective depression, hopelessness and suicidal ideation were greater in suicide
attempters than in non-attempters despite comparable rates of objective severity for
depression or psychosis. One stressor is almost invariably the onset or acute worsening of
a psychiatric disorder, but other types of stressors, such as a psychosocial crisis, can
also contribute. The diathesis for suicidal behaviour includes a combination of factors
such as sex, religion, familial and genetic components, childhood experiences,
psychological support system, availability of highly lethal suicide methods and various
other factors (Mann, 2002).
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Figure 1. A model for suicidal behaviour
                                                Depression
                                                or
    Objective state                             Psychosis
                                                Life events
                                         Hopelessness
                                         Perception of depression
                                         Suicidal ideation
    Subjective state and traits          Suicidal planning
  Low serotonergic activity              Impulsivity                          Aggressivity
  Alcoholism, smoking,                   Suicidal act
  substance abuse,
  head injury
         Mann JJ et al. Am J Psychiatry 1999;156:181-189.
         Reprinted with a permission of American Psychiatric Association.
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2.2.3.2 Differential activation theory
Teasdale et al. (1988) proposed a differential activation theory (DAT), which suggests
that during episodes of depression, associations are formed between sad mood and a
constellation of negative processing bias. With each occurring episode of depression, the
network of depressive cognitions is strengthened, elaborated and becomes increasingly
accessible. Recently Joiner et al. (2003) and Lau et al. (2004) suggested that this theory
could be extended to the explanation of recurrence of suicidal behaviour. Painful and
fear-inducing qualities of suicidal behaviour can diminish with repetition, while opposing
processes may intensify. Williams et al. (2005a; 2005b; 2006) refined this theory further
in their reports. DAT suggests that the risk of future suicidality is dependent on the
extent to which suicidal thoughts and plans have become a part of the processing pattern
that is reactivated when low mood reoccurs.
2.3 Suicidal ideation
2.3.1 Definition of suicidal ideation
Suicidal ideation is defined as thoughts serving the agent of one’s own death. It may vary
in seriousness depending on the specificity of suicide plans and the degree of suicidal
intent (American Psychiatric Association, 2003). Suicidal ideation can be manifested from
transient thoughts with respect to the worthlessness of life and death wish, to permanent,
concrete plans for killing oneself and obsessive preoccupation with self-destruction.
Suicidal ideation may be an aspect of depressed mood and also from the other point of
view, a coping strategy with such a mood. It is also correlated closely with hopelessness.
Suicidal ideation can be of a habitual or chronic as well as of an acute nature (Goldney
et al., 1989; Diekstra & Garnefski, 1995).
2.3.2 Epidemiology of suicidal ideation
Suicide ideation, which comprises suicidal thoughts or threats devoid of action, is more
common than suicide attempts and completed suicides and its prevalence varies widely.
Lifetime prevalence of suicidal ideation has been reported to range from 2% to 18%
(Kessler et al., 1999; Weissman et al., 1999). In epidemiological studies the prevalence
of suicidal ideation has been reported since the 1970s. Depending on the setting of each
particular study, the 12-month prevalence has varied from 2.3% to 8.7% (Schwab et al.,
1972; Paykel et al., 1974; Vandivort & Locke, 1979; Crosby et al., 1999, Goldney et al.,
2000). In the well-known large epidemiological studies National Comorbidity Survey (NCS)
and National Comorbidity Survey-Replication (NCS-R), the 12-month prevalence of suicidal
ideation was found to be 2.8% and 3.3%, respectively (Kessler et al., 1999; 2005). Kessler
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et al. (2005) estimated that there are approximately 3000/100 000 suicide ideators in the
United States each year with 14/100 000 suicide completers. In a Greek study, Madianos et
al. (1993) reported the prevalence of suicidal ideation by gender for two waves, 1978 and
in 1984. In the first wave, 2.8% of males and 6.8% of females reported suicidal ideation
during the last 12 months and in the second, 5.9% and 14.9%, respectively.
Suicidal ideation can vary significantly in different age groups. Suicidal ideation among
young adults has been suggested to be around 10-12% (Goldney et al., 1989) while it is 4%
among the elderly (Skoog et al., 1996).
In the Finnish study Hintikka et al. (2001) investigated with questionnaires (BDI) in a
nationwide sample the incidence of suicidal ideation both at the baseline and at 12-month
follow-up. The incidence of overall suicidal ideation was reported as 3.8%, and 3.1% for
females and 4.6% for males, respectively. Usually suicidal ideation is equally common
among males and females, or slightly more common among females, but in Finland this does
not seem to be the case.
Table 1. Risk factors for suicidal behaviour.
Variable Suicidal Ideation Suicide Attempt Completed Suicide
Gender                                female/male             female                  male
Age                                   younger                 younger                 advancing
Marital status                        non-married / single    divorced                single / divorced / widowed
Education                             +/-                     low
Economical problems / unemployment    +                       +
Psychiatric disorders
     Major Depressive Disorder        +                       +                       +
     Personality disorders                                    +                       +
     Substance Use Disorder           +                       +                       +
     Anxiety disorders                +                       +                       +
Hopelessness                          +                       +                       +
Chronic physical illness              +                                               +
Negative life events                  +                       +                       +
Social support                        low
Childhood abuse and other experiences                         +
Parental psychopathology                                      +
Suicidal behaviour in the past
     Previous suicidal ideation                               +                       +
     Previous suicide attempts                                +                       +
     Family history of suicide                                +                       +
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2.3.3 Risk factors for suicidal ideation
Suicide  research   has  mainly  focused on  suicide  attempts   and  completed  suicides  and
relatively few studies have focused on suicide ideation. Prior research suggests a variety
of risk factors for suicide ideation. Thoughts of suicide appear to be unrelated to gender
(Murray, 1973; Friedman et al., 1987; Sorenson & Rutter, 1991), with exceptions (Paykel et
al., 1974; Pages et al., 1997; Kessler et al., 2005) or educational attainment (Kinkel et
al., 1988; Sorenson & Rutter, 1991), (exception Kessler et al., 2005), but may be more
prevalent among non-married / single and younger individuals (Sorenson & Rutter, 1991;
Zimmerman et al., 1995; Kessler et al., 2005). Also low self-esteem (de Man et al., 1992),
limited probem-solving ability (Priester & Clum, 1993; Dixon et al., 1994), hopelessness
(Beck et al.,1979; Rudd, 1990; Rudd et al., 1993; Hintikka et al., 1998; Vilhjalmsson et
al., 1998), dissatisfaction, pessimism, anxiety / anxiety disorders (Rudd et al., 1993;
Vilhjalmsson et al., 1998; Sareen et al., 2005), mental illness, especially major
depressive disorder (Paykel et al., 1974; Beck et al., 1979; Smith & Crawford, 1986;
Kinkel et al., 1988; Rudd, 1990; Kandel et al., 1991; Sorenson & Rutter, 1991; Breslau,
1992; Rudd et al., 1993; Hintikka et al., 1998; Vilhjalmsson et al., 1998), as well as
chronic pain or chronic conditions (Paykel et al., 1974; Breslau, 1992; Ingersoll et al.,
1993; Vilhjalmsson et al., 1998), substance use disorder (Kinkel et al., 1988; Kandel et
al., 1991; Murphy et al., 1992; Bartels et al., 1992; Burge et al., 1995; Pages et al.,
1997; Vilhjalmsson et al., 1998), stress in general (Paykel et al., 1974; Kandel et al.,
1991, de Man et al., 1992), negative life events (Paykel et al., 1974), family
difficulties (Kandel et al., 1991), economical problems (Kandel et al. 1991; Vilhjalmsson
et al., 1998; Kessler et al., 2005) and low social support (Paykel et al., 1974; Kinkel et
al., 1988; Kandel et al., 1991; de Man et al., 1992) have been found to be associated with
suicidal ideation. The most consistent factors identified as risk factors of suicidal
ideation have been depression and hopelessness. These findings seem to be unrelated to
geographic location or age of the population studied. (Table 1).
2.4 Suicide attempt
2.4.1 Definition of suicide attempt
Suicide attempt is defined as self-injurious behaviour with a non-fatal outcome accompanied
by evidence (either explicit or implicit) that the person intented to die (American
Psychiatric Association, 2003). According to Skegg (2005) attempted suicide as a term is
used for episodes where there was at least some suicidal intent, or sometimes without
reference to intent. On the other hand, deliberate self-harm is also used along suicide
attempt. Deliberate self-harm is defined as willful self-inflicting of painful,
destructive, or injurious acts, but without intent to die. Deliberate self-harm is used
especially in the UK (American Psychiatrtic Association, 2003; Skegg, 2005).
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2.4.2 Epidemiology of attempted suicide
Official statistics on attempted suicide are not usually collected annually, as is the
case for completed suicides, but several epidemiologic surveys have reported
population-based estimates of lifetime prevalence of a suicide attempt (Paykel et al.,
1974; Moscicki et al., 1988; Kessler et al., 1999; Weissman et al., 1999; Norlev et al.,
2005). The estimates have ranged from 0.7% to 5.9%. The 12-month prevalences have ranged
from 0.19% to 0.6% (Petronis et al., 1990; Kessler et al., 1999; 2005). In NCS and NCS-R
Kessler et al. (1999; 2005) reported 12-month prevalences of suicide attempts as 0.4% and
0.6%, respectively. Accordingly, this means that there are approximately 500 suicide
attempters per 100 000 population in the US each year.
As a part of the WHO/EURO Multicentre Study on Parasuicide, the rates of attempted suicide
among persons aged 15 and over for the period 1989-1992 were reported. In Helsinki,
Finland, the rate of attempted suicide for males was 314/100 000 and for females 246/
100 000. With only one exception (Helsinki), the person-based suicide attempt rates were
higher among females than males, approximately 2:1 (Schmidtke et al., 1996).
Suicide attempts are more common among the young people than the elderly, whereas
completed suicide is more common among the elderly. Between 2% to 12% (median 6%) of
young people report a lifetime history of suicide attempt (Beutrais, 2002).
A suicide attempt is one of the strongest predictors of the subsequent suicide. The risk
of suicide after an attempt is up to 40 times the expected rate (Harris & Barraclough,
1997; Suominen et al., 2004a). In recent Finnish studies 5 to 8% of suicide attempters
commited suicide during the follow-up period and the risk of suicide was highest during
the first year following the index attempt (Ostamo & Lönnqvist, 2001; Suokas et al., 2001;
Suominen et al., 2004a; 2004b). Geographically suicide attempt rates in Finland among both
sexes are higher in urban than in rural areas. Male rates are higher than female rates in
almost every area under study, from south to north, east to west (Ostamo et al., 1991).
2.4.3 Risk factors for attempted suicide
Risk factors for attempted suicide have been the focus of numerous studies during the past
decades. Psychiatric disorders, especially MDD, have been found in several studies to be a
major risk factor (Suominen et al., 1996; Mann, 1999; Beautrais, 2001). Suominen et al.
reported that at least one Axis I diagnosis was made in 98% of the suicide attempters,
while over 70% of the cases suffered from depressive disorders and about 50% from alcohol
dependence or abuse (Suominen et al., 1996). The association between female gender and
attempted suicide is also well known (Schmitdke et al., 1996; Beutrais, 2002). The other
risk factors for attempted suicide listed extensively by Mann (1999), Beautrais (2001;
2002) and Skegg (2005) in their reports include demographic factors such as younger age,
divorce, unemployment; such socioeconomic disadvantages, as low income, low educational
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status or poverty, social and familial factors such as childhood abuse or other adverse
childhood experiences: parent’s separation or divorce, parental psychopathology, social
isolation; comorbid psychiatric illnesses, such as personality disorders, substance use
disorders, or anxiety disorders ; hopelessness, fewer reasons for living, subjective
suicidal ideation, higher lifetime rate for aggression and impulsivity, family/personal
history of suicidal acts, recent stressful life events and prior outpatient psychiatric
treatment. Some factors may also be of protective nature, such as religion, cultural norms
or social support. Often risk factors and protective factors are interlinked (Skegg,
2005). The most consistent risk factor is the presence of a psychiatric disorder, most
commonly depression, followed by substance abuse and anxiety disorders. (Table 1).
2.5 Suicide
2.5.1 Definition of suicide
Suicide is defined as self-inflicted death with evidence (either explicit or implicit)
that the person intented to die (American Psychiatric Association, 2003).
2.5.2 Epidemiology of suicide
Suicide has become a major public health issue around the world. It is among the leading
causes of death, and suicide accounts for more deaths than the number due to HIV infection
and AIDS combined, or due to homicide and war combined. In Finland the suicide rate is
among the highest in Europe (19.7/100 000 in 2004), although it is well worth noticing
that there has been a 30% decline during the past 15 years (Figure 2). In USA, for
example, the suicide rate is 13.9/100 000 (2002) and in Sweden 13.4 /100 000 (2001). The
highest annual suicide rates are in Eastern Europe, especially in the Baltic countries and
former Soviet republics (> 27/100 000) and the lowest in Latin American and Islamic
countries (< 6.5/100 000). Men have a higher rate of completed suicide than women, usually
the male to female ratio is approximately 3-4:1 (World Health Organization, 2005). Because
suicide is more open to cultural, ethnic and religious influences, the rates vary
significantly among the various age groups, gender and different countries.
In psychological autopsy studies, most have found that over 90% of the suicide completers
had a psychiatric disorder at the time of death, and approximately 60% of all suicides
occur in persons with mood disorder (Mann, 2002). Propensity for lifetime mortality for
suicide in discharged hospital population remains high, although in recent years there has
been a downrating of the risk (Blair-West et al., 1999). Up to 50% of the people who
commit suicide are intoxicated at the time of death (Moscicki, 2001) and 11% of completed
suicides had a first-degree relative who had committed suicide (Maris, 2002).
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Figure 2. Suicide mortality in Finland 1990-2004
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Vuosi 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004   
Males  50.1 49.2 46.6 44.6 43.5 42.8 38.0 41.0 37.9 37.5 33.7 35.7 32.0 31.0 31.1
Females  12.1 11.3 11.1 10.8 11.3 11.5 10.3 10.3  9.7  9.2 10.6  9.5  9.5  9.1  9.1
Total  30.0 29.3 28.2 26.9 26.8 26.6 26.6 25.1 23.1 22.8 21.8 22.3 20.3 19.7 19.7
2.5.3 Risk factors for completed suicide
Psychological autopsy is probably the most direct technique currently available for
determining the relationship between particular risk factors and suicide (Isometsä, 2001;
Cavanagh et al., 2003). Suicide has a strong association with psychiatric disorders. More
than 90% of the suicide victims have a diagnosable psychiatric illness, usually MDD,
alcohol dependence/abuse or personality disorder (Barraclough et al., 1974; Henriksson et
al., 1993, Cheng, 1995; Cavanagh et al., 2003, Arsenault-Lapierre et al., 2004). The
majority of suicide victims suffer from co-morbid mental disorders (Henriksson et al.,
1993). Hopelessness, suicidal ideation and previous suicide attempts are strong and
independent risk factors (Appleby et al., 1999; Brown et al., 2000; Beck, 2001). Those who
have attempted suicide carry a risk of eventual suicide that is about 100 times greater
than that of the general population during the year following the attempt (Hawton, 1987).
The role of previous suicide attempts can be also seen as an indicator of future suicide
risk. In their paper Joiner et al. (2003) discussed the fact that as suicidal ideation is
related to subsequent completed suicide, a lifetime history of suicide attempts can lower
the threshold of new attempts and thus, suicide related structures may become more easily
triggered. Suicide attempt may be considered to be a better risk indicator for completed
suicide than a risk factor expressing causality between an attempt and suicide. Male
gender, advancing age, poor physical health, high intention of previous suicide attempts,
being widowed /divorced/living alone, recent adverse life events, severe anxiety, chronic
medical illness and family history of suicide are also known risk factors (Cheng, 1995;
Vijayakumar & Rajkumar, 1999; Suokas et al., 2001; Mann, 2002; Gaynes et al., 2004;
Suominen et al., 2004a; 2004b). (Table 1).
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2.6 Prevention of suicidal behaviour
Primary prevention of suicide is the ideal method of protection. It requires broad
modifications in social, economic and biological conditions to prevent certain members of
a population from becoming suicidal. Primary prevention is directed at social
interventions early in suicidal pathways. This approach forces interventions at the level
of the environment and the means of self-destruction, rather than focusing on the
individual at risk (Maris, 2002).
The prevention of suicidal ideation and suicide attempts serves ultimately as prevention
of new suicides.
Primary preventive measures or protective factors could include reduction of divorce rates
and violence (especially in families), restricting access to lethal methods (firearms,
pesticides, toxic gas, barbiturates etc.), promoting physical health, proper exercise,
diet, sleep etc. (Maris, 2002; Mann et al., 2005). Public education campaigns are popular
and they increase knowledge and improve attitudes toward mental illness and suicide, but
measures for suicide prevention have been insufficient (Mann et al., 2005).
As secondary prevention options (e.g. when members of population become suicidal),
probably the best protective measures are early detection of suicidal individuals,
accurate diagnosis and effective treatment of psychiatric disorders (especially MDD).
Suicide prevention at this stage is possible because of completed suicides at least 83%
had had contact with a primary care physician within a year of their death, and up to 66%
within a month (Andersen et al., 2000; Luoma et al., 2002). Therefore, improving a
physician’s recognition of depression and suicide risk evaluation is a significant
component of suicide prevention. Several studies examining suicidal behaviour in response
to primary care education programs, mostly targeting on depression recognition and
treatment, have all reported positive results (Mann et al., 2005). From pharmacological
treatment forms for example lithium is effective in the prevention of suicide, deliberate
self-harm, and death from all causes in patients with mood disorders (Cipriani et al.,
2006). Thus, physician education in depression recognition and treatment is probably the
most plausible method of secondary suicide prevention.
Recently many studies have used the method of population attributable risk (PAR)
statistics, which measures the proportion of the condition that can be associated with
exposure to a risk factor, or the proportion of the condition that would be eliminated if
the risk factor were not present. Beautrais reported that the elimination of mood
disorders would result in an 80% reduction in the risk of serious suicide attempt and 37%
to 46% reduction in suicide rates (Beautrais et al., 1996; 1999). Similarily Pirkis et al.
(2000) and Goldney et al. (2000; 2003) reported 39% to 57% reduction for suicidal ideation
and 40% for attempted suicide.
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Given the rarity of completed suicides, health care services have to acknowledge that many
patients may need to be targeted in order to prevent few suicides. However, the components
of suicide prevention, such as increased clinical supervision, encouragement of
compliance/adherence, and improved patient management, will result in improved medical
care for severely ill patients (Appleby et al., 2005).
Persons with a history of admission to a psychiatric hospital were at high risk of
suicide, and the suicide risk peaks during periods immediately after admission or
discharge. Suicide risk is significantly higher in patients who received less than the
median duration of hospital treatment (Qin & Nordentoft, 2005). The risk of suicide among
patients incapacitated for one year or less after first admission increases significantly
in the first year after discharge, according to Danish studies (Mortensen et al., 2000;
Höyer et al., 2000).
Figure 3. Targets of Suicide Prevention Interventions
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2.7 Major depressive disorder (MDD)
Depression is a common mental disorder characterized by sadness, loss of interest in
activities and diminished energy. Depression is differentiated from normal mood changes by
the extent of its severity, the symptoms and the duration of the disorder.
Major depressive disorder, in particular, is highly prevalent, aetilogically
multifactorial, clinically heterogeneous, frequently follows a recurrent or chronic
course, and significantly impairs the quality of life. MDD is among the leading cause of
burden among all diseases and the leading cause of years lost due to disability (YLDs) in
2000 (Murray & Lopez, 1996).
2.7.1 Diagnosis of MDD
The diagnostic classifications currently in use are the DSM (American Psychiatric
Association, 1987; 1994; 2000) and the International Statistical Classification of
Diseases and Related Health Problems (ICD) (World Health Organization, 1992; 1993;
Tautiluokitus 1996).
In DSM-IV, unipolar forms of primary mood disorders are classified into three groups: MDD,
dysthymic disorder, and depression not otherwise specified. MDD is characterized by one or
more major depressive episodes (MDEs) lasting at least two weeks. Earlier DSM-III-R used
term ’major depression’ (MD) for MDD. However, diagnostic criteria remained the same. At
least five symptoms are present during the same 2-week period and represent a change from
one’s previous functioning; in order to fulfill the criteria for MDD at least one of the
symptoms is either 1) persistent depressed mood or 2) loss of interest or pleasure, which
is accompanied by at least four of the following symptoms (total of five symptoms):
significant weight change, insomnia or hypersomnia, psychomotor agitation or retardation,
fatigue or loss of energy, feeling of worthlessness or excessive or inappropriate guilt,
diminished ability to think or concentrate or indecisiveness, recurrent thoughts of death,
suicidal ideation, or suicide attempt, (American Psychiatric Association 1987; 1994,
2000). Based on the number of criteria symptoms, the severity of symptoms, and the degree
of disability, an episode of MDD may be classified as mild, moderate, or severe. The
symptoms should not be the result of a direct physiological effect of a substance or a
general medical condition or bereavement.
With ICD-10, the diagnosis of MDD is basically similar to the DSM-IV. Still, ICD-10
requires one symptom less than DSM-IV for diagnosis, fatigue or loss of energy is included
in core symptoms with persistent depressed mood and loss of interest or pleasure, and
feelings of worthlessness or inappropriate guilt is split into two symptoms. Research
programmes usually apply the DSM classification. ICD-10 is in clinical use in Finland.
In this thesis, unless otherwise specified, depression refers to unipolar DSM-IV MDD.
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2.7.2 Epidemiology of MDD
The prevalence of depressive disorders in the general population has been estimated in
numerous epidemiological studies and surveys around the world (WHO World Mental Health
Survey Consortium 2004). Various epidemiological studies show that depression, compared
with other medical diagnoses, is highly prevalent in the general population (Jenkins et
al., 1997; Kessler et al., 1994; 2003; Jacobi et al., 2004). It is estimated that during
their lifetime, approximately one fifth of the population will experience an episode of
MDD (Kessler et al., 1994). It occurs twice as frequently in women than in men, can begin
at any age, but on average the age of onset is in the mid-20’s (Kessler et al., 2003).
In Epidemiological Catchment Area (ECA) study the prevalence estimates of MDD were 3.0%
for a current and 5.2% for lifetime disorder. In NCS and later NCS-R, Kessler et al.
(1994; 2003) reported a lifetime prevalence of MDD of 14.9% and 16.2% and a 12-month
prevalence of 8.6% and 6.6%, respectively, in the population of US. Recently, in another
large study, the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC),
Hasin et al. (2005) reported the prevalence of lifetime DSM-IV MDD of 13.2% and 12-month
prevalence of 5.3%.
In the Netherlands Mental Health Survey and Incidence Study (NEMESIS) Bijl et al. (1998)
reported the lifetime prevalence of DSM-III-R major depression to be 15.4% and 12-month
prevalence of 5.8% in a Dutch population, and recently, in a large European multi-centred
study (ESEMed) of Belgium, France, Germany, Italy, the Netherlands and Spain the
prevalences were 12.8% and 3.9%, respectively (Alonso et al., 2004). Wittchen and Jacobi
(2005) analysed in their study the results of 17 European studies and found out that
estimates for 12-month prevalence of MDD range from 3.1% to 10.1%, with the median being
6.9%.
In a recent Finnish study Pirkola et al. (2005) reported a 12-month prevalence of MDD of
4.9% based on the Health 2000 study, while in a Finnish Health Care Survey (FINHCS)
Lindeman et al. (2000) found the 12-month prevalence of MDE to be 9.3%. The difference in
the prevalence may be explained by the diagnostic interview (M-CIDI) used with its
stringent exclusion criteria in recent Health 2000 study (Pirkola et al., 2005).
In the Mini Finland Health Survey, Lehtinen & Joukamaa (1994) reported that only one third
of the persons suffering from clinically significant depression were actually being
treated for their disorder. However, only about 50% of those with major depressive episode
or dysthymia perceive need for mental health services (Isometsä et al., 1997). In FINHCS
Hämäläinen et al. (2004) reported that only 59% of those suffering from the severest major
depression episodes use health services for depression.
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2.7.3 Aetilogy of MDD
MDD is a prototypical multifactorial disorder, aetilogically complex disorder (Kendler et
al., 2002; 2006). An individual’s risk of suffering an episode of MDD is influenced by
factors from multiple domains, including genetic influences (Tsuang & Faraone, 1990;
McGuffin et al., 1996; Sullivan et al., 2000; Caspi et al., 2003; Korszun et al. 2004;
Lesch, 2004), poor parenting/maternal stress during pregnancy/parental depression (Parker,
1979; Holmes & Robins, 1988; Oates, 2002; O’Connor et al., 2002; Lyons-Ruth et al., 2002;
Lieb et al., 2002), childhood sexual or physical abuse (Ferguson & Mullen, 1999; Heim et
al., 2000; Gladstone et al., 2004), premature parental loss (Tennant, 1988), predisposing
personality traits (Angst & Clayton, 1986; Hirschfeld et al., 1989; Boyce et al., 1991;
Caspi et al., 1996; Kendler et al., 2004), early onset of an anxiety disorder (Breslau et
al., 1995; Kessler et al., 1996; Young et al., 2004), low social support (Hendersson,
1992; Cooper & Paykel, 1994), substance misuse (Kessler et al., 1996), marital
difficulties (Whisman et al., 2000), a prior history of MDD (Lewinsohn et al., 1988;
Harrington et al., 1990), and recent stressful life events (Paykel et al., 1969; Brown &
Harris, 1978; Kessler, 1997; Kendler et al., 2004). Some of these aetilogical factors have
also been shown to interact. Caspi et al. (2003) reported gene-by-environment interaction,
in which an individual’s genetic makeup moderates his/her response to environmental
factors. Individuals with one or two short allele of the 5-HTT promoter polymorphism
exhibited more depressive symptoms, diagnosable depression and suicidality in relation to
stressful life events than individuals homozygous for the long allele. Kendler et al.
(2004) reported the interaction between life events and neuroticism, where neuroticism has
a greater impact on MDD risk at high levels of adverse life events.
2.7.4 Heritability of MDD
Several studies have focused on the heritability of depression, and the estimates reported
range from 20% up to 70% (usually 20-45%) (Sullivan et al., 2000; Wallace et al., 2002;
Lesch, 2004). Sullivan et al. (2000) reported strong evidence for an association between
MDD in the proband and MDD in the first-degree relatives (OR 2.84). Major depression is a
familial disorder and its familiality mostly or entirely results from genetic influences.
Recently, Kendler et al. (2006a) found heritability of MDD higher in women (42%) than in
men (29%). However, heritability is always related to a specific population.
2.7.5 Developmental factors of MDD
MDD is a disorder with many aetilogic variables that are interrelated through
developmental pathways. Kendler et al. (2002; 2006b) have constructed a developmental
model for MDD in women and in men. They created a model to predict depressive episodes in
the year before the most recent interview. Eighteen risk factors conceptualized as five
developmental tiers reflecting childhood (genetic risk, disturbed family environment,
childhood sexual abuse, childhood parental loss), early adolescence (neuroticism,
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self-esteem, early onset of anxiety and conduct disorder), late adolescence (educational
attainment, lifetime traumas, social support, substance misuse), adulthood (history of
divorce, past history of depression), and the preceding year (marital problems,
difficulties, stressful life events). The overall results suggest that the development of
MDD for both men and women results from the interaction of internalizing/externalizing
symptoms and adversity. Childhood loss and low self-esteem were more potent variables in
the model for men than in women. Also genetic risk factors seemed to have a broader
spectrum of impact in men than in women, but from an aetilogic perspective, major
depression is largely the same disorder in men and women.
2.7.6 Course and outcome of MDD
The data reported on the duration of an episode of MDD has varied in different studies,
depending on the specific study, the population concerned and methodology used. Eaton et
al. (1997) reported a duration of MDE of twelve weeks from the ECA, Spijker et al. (2002)
reported median duration of three months from the NEMESIS study, and Kessler et al. (2003)
sixteen weeks from NCS-R. Recently Hasin et al. reported a median duration for MDE to be
24 weeks in the general adult US population (Hasin et al., 2005). Hämäläinen et al. (2004)
studied other median durations of the episodes and reported 4 weeks for mild episode, 5
weeks for a moderate one and 9 weeks for severe major depressive episode. The duration of
an MDE was also associated with the severity of depression. Longer duration and greater
severity of MDD are related to the referral to health services and psychiatric care. The
severity of the depression and longer duration of MDE before treatment predict a longer
episode of MDE (Melartin et al., 2004).
MDD is a chronic disorder and has a high risk of recurrence. Significant numbers of people
(up to 80%) who have experienced MDD will experience at least one more episode of MDD
later during their lifetime, and 20% will have a chronic course of MDE lasting more than 2
years (Angst, 1986; Keller et al., 1992; Brodaty et al., 2001).
2.7.7 Comorbidity of MDD
Comorbidity is defined as the occurrence of two or more disorders in a person in a defined
period of time (Klerman, 1990). Comorbidity in depression has been the topic of numerous
studies over the years. Comorbid MDD is so common that it is almost exceptional not to
have a comorbid disorder in connection with MDD (Kessler et al., 1996). MDD patients have
generally at least one comorbid Axis I disorder (Placidi et al., 2000, Melartin et al.,
2002; 2004; Merikangas et al., 2003; Alonso et al., 2004; Hasin et al., 2005; Vuorilehto
et al., 2005). In NCS-R, over 70% of lifetime and almost 80% of 12-month MDD patients, had
at least one comorbid disorder, including 59% with anxiety disorder, 24% with substance
use disorder and 30% with impulse control disorder (Kessler et al., 2003).
Only a few studies have assessed Axis II comorbidity in MDD in the same population. In a
European multicentred study Casey et al. (2004) found the overall prevalence of
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personality disorders to be 22% in a community sample with depressive disorders, while
Hasin et al. (2005) reported in their recent study a prevalence of 38% for any personality
disorder. The most common disorders were obsessive-compulsive, paranoid, schizoid and
avoidant personality disorder.
2.7.8 Treatment of MDD
During the last decade several sets of evidence-based treatment guidelines have been
published in order to improve the detection and treatment of MDD. These guidelines cover
the priciples and goals of psychiatric management with psychotherapeutic approaches,
pharmacotherapy (antidepressant medications), combination of psychotherapy and medication,
ECT, bright light therapy, among others (Schulberg et al., 1998; Crismon et al., 1999;
Anderson et al., 2000; APA, 2000; Bauer et al. 2002; Suomen Psykiatriyhdistys, 2004;
National Institute of Clinical Excellence, 2004). Other available forms of treatment for
MDD include antipsychotic drugs and mood stabilizers, especially in combination with
antidepressants (Mann, 2005, Wijkstra et al., 2005), exercise (Ernst et al., 2006), sleep
deprivation (Tsuno et al., 2005), ethyl-eicosapentaenoic acid (EPA) (Parker et al., 2006)
and hopefully in the future transcranial magnetic stimulation (TMS), deep brain
stimulation (DBS) and vagus nerve stimulation (VNS) (Eltan & Lerer, 2006). The most used
treatments in Finland are antidepressant treatment, psychotherapy and ECT.
2.7.8.1 Antidepressant treatment
The pharmacotherapy of depression can be divided into three phases: acute, continuation
and maintenance treatment. In the acute phase, the aim of the treatment is full remission,
in the continuation phase, the prevention of relapse, and in the maintenance phase, it is
the prevention of recurrence (Suomen Psykiatriyhdistys, 2004).
Depression can be effectively treated with antidepressants. Antidepressant pharmacotherapy
is more important the more severe the depression is, and always indicated if depression is
severe or psychotic. In mild or moderate cases of depression, effective psychotherapy,
alone or combined with pharmacotherapy, are possible alternative treatments (Suomen
Psykiatriyhdistys, 2004). As the effectiveness of available antidepressants is comparable,
the selection of medication will be based on the side-effect profile, the safety and
tolerability, interaction, and the patient’s preference. Antidepressant doses must comply
with treatment guidelines (American Psychiatric Association, 2000; Suomen
Psykiatriyhdistys, 2004). The effect size of antidepressive medication in depression
ranges from 0.51 to 1.09 (Khan et al., 2004, DeRubeis et al., 2005).
Antidepressant treatment should be maintained in the continuation phase for approximately
four to nine months after remission, in order to prevent relapse. Long-term maintenance
treatment should be considered to prevent recurrences (American Psychiatric Association,
2000; Suomen Psykiatriyhdistys, 2004). There are several factors that need to be
considered in the decision whether or not to use maintenance treatment. These factors
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include the risk of recurrence (number of prior episodes, presence of comorbid conditions,
residual symptoms between episodes), severity of the episodes (presence of suicidality,
psychotic features or severe functional impairments), possible side-effects experienced
and patient preferences (APA, 2000).
2.7.8.2 Psychotherapeutic treatment
In the treatment of depression, the aim of psychotherapeutic treatments is to alleviate
depression by influencing the psychological and behavioural factors that induce and
maintain depression. Psychotherapy that can be applied in the treatment of depression
include cognitive or cognitive-behavioural therapy (CBT), interpersonal psychotherapy
(IPT), brief psychodynamic psychotherapy, and cognitive problem-solving therapy. In acute
phase of mild or moderate depression, psychotherapy can be used either alone, or combined
with pharmacotherapy. In the continuation and maintenance phases, treatment of residual
symptoms by psychotherapeutic means can be useful in order to prevent recurrence (Suomen
Psykiatriyhdistys, 2004). The effect size of CBT has been reported to be from 0.44 to 0.68
(DeRubeis et al., 2005, Haby et al., 2006)
2.7.8.3 Electroconvulsive Therapy (ECT)
ECT has been used as a treatment for mental disorders since the 1930s. ECT is one of the
most controversial treatments in public opinion and media. There is evidence that it is an
effective treatment for psychotic and severe depression, and should be used if
pharmacotherapy has not been effective, or rapid response is otherwise necessary (e.g. due
to acute severe suicidality). ECT is an effective short-term treatment for patients with
major depressive disorder, bilateral ECT moderately more effective than unilateral and
high dose ECT is more effective than low dose (The UK ECT Review Group, 2003). Earlier
research indicates that ECT is at least as effective (or probably more) as antidepressant
medication for the treatment of major depression (SES -0.80, 95% CI -1.29 to -0.29)
(Weiner, 1994; UK ECT Review Group, 2003); nonetheless, ECT is used only rarely as a
first-line treatment (American Psychiatric Association, 2000).
2.7.9 Adherence and attitudes to treatment
There is a variety of terminology in literature relating to the degree to which a patient
follows treatment regimen. It is suggested that the term adhererence is preferable, as it
it puts greater emphasis on the role of the clinician in forming a therapeutic alliance,
and on the active rather than the passive participation of the patient in this process
(Lingam & Scott, 2002). The term adherence is defined as "patient acceptance of
recommended health behaviours" (Wright, 1993). Adherence is a major problem in the
treatment of depression (Pampallona et al., 2002). The successful treatment of MDD
requires close adherence to treatment plans. Those who continue therapy with their initial
antidepressant are least likely to experience relapse or recurrence and those who
discontinue using their antidepressant early are most likely to have relapse or recurrence
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(Melfi et al., 1998). Psychiatrists are encouraged to question their patients about their
concerns about adherence. Patients with MDD may be poorly motivated, pessimistic about
their chances of recovery with treatment, or careless with their wellbeing. Side effects
may often lead to non-adherence (American Psychiatric Association, 2000). Adherence to
treatment guidelines could be improved throughout the adjustment of antidepressant dosage,
reduction of benzodiazepine prescriptions, enhanced use of ECT and wider use of
interpersonal therapy (Schneider et al., 2005).
Methods used to measure non-adherence have ranged widely. Patient self-reporting is
probably the most accurate method (Stephenson et al., 1993). Although it is affected by
low sensitivity (about 50%), it generally has high specifity (90%) (Lingam & Scott, 2002).
The importance of patients’ attitudes and health beliefs have been increasingly
emphasized. Sirey et al. (2001) reported that patients’ perception of the stigma of
depression at the start of treatment was indicative of their subsequent medication
adherence. Attitudes toward antidepressants directly affect the patient’s willingness to
continue on an extended course of treatment (Mitchell, 2006). Reported rates of
non-adherance with antidepressant medication in depressive disorders range from 10 to 60%
(median 40%), and 42% of patients discontinue their antidepressant medication during the
first 30 days and 72% within 90 days (Lingam & Scott, 2002; Olfson et al., 2006). Still,
only 1-2% of all publications on the treatment of affective disorders have explored the
factors associated with non-adherence, and thus there is a considerable lack of
understanding the factors that predict adherence (Lingam & Scott, 2002).
2.8 Suicidal behaviour in MDD
2.8.1 Epidemiology of suicidal behaviour in MDD
Numerous studies have documented an association between suicidal behavior – completed
suicide, suicide attempt, and suicidal ideation – and MDD.
A well known meta-analysis (Harris & Barraclough, 1997) and two nationwide studies from
Scandinavia (Höyer et al., 2000; Ösby et al., 2001) indicate that an inpatient with MDD
has about a 20-fold risk of completed suicide. The risk of a non-fatal suicide attempt
among patients with MDD is less precisely known, but is estimated to be about 40% after
the first lifetime episode of MDD (Malone et al., 1995) and the rate of repetition of
attempt within a year is approximately 25% (Brådvik, 2003).
Depending on the definition applied, the prevalence of suicidal ideation ranges from 47%
to 69 % in patients with MDD (Asnis et al., 1993; Bronisch & Wittchen, 1994; Zisook et
al., 1994). Various types of non-fatal suicidal behavior tend to be highly prevalent among
patients with MDD, who also have a markedly increased risk of completed suicide, of which,
non-fatal suicidal behavior is perhaps the most important risk indicator (Harris &
Barraclough, 1997). The main cause of increased mortality in depression is suicide.
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Findings from the psychological autopsy studies conducted over the past decades suggest
that depression is evident in 29-88% of all suicides (Lönnqvist, 2000).
While the three types of suicidal behavior – ideation, suicide attempt and completed
suicide – probably represent a continuum of self-harming behaviours (Beck, 1986; Smith &
Crawford, 1986; Bonner & Rich, 1987; Diekstra, 1993; Vilhjalmsson et al., 1998; Hawton &
Van Heeringen, 2000; Beautrais, 2001), research on both types of non-fatal behavior
contributes to suicide prevention. More than half (52%) of subjects completing suicide in
major depression die in their first attempt, yet many of these first-timers have made
their intent known. Further, about half of MDD subjects completing suicide had attempted
suicide at least once before (Isometsä et al., 1994). Therefore recognizing both suicidal
ideation as well as suicide attempts as important risk indicators, is likely to improve
sensitivity in predicting suicide risk; investigating the risk factors for both may also
reveal more information about the particular risk factors for completed suicide.
Table 2. Risk factors for suicidal behaviour in major depressive disorder. 
Variable Suicidal Ideation Suicide Attempt Completed Suicide
Gender                                female                                          male
Age                                   younger                 younger                 advancing
Marital status                                                marital isolation
Education                             +/-                     low
Economical problems / unemployment    +
Severity of MDD                       +                       +                       +
Comorbid psychiatric disorders
     Personality disorders            +                       +                       +
     Substance Use Disorder           +                       +                       +
     Anxiety disorders                +                       +                       +
Hopelessness                          +                       +                       +
Negative life events                  +                       +
Social support                        low
Suicidal behaviour in the past
     Previous suicidal ideation                               +                       +
     Previous suicide attempts        +                       +                       +
     Family history of suicide                                +                       +
2.8.2 Risk factors for suicidal ideation in MDD
The  studies   that  have   investigated  the   risk  factors  of  suicidal  ideation  in  depression
have consistently identified the severity of depression (Van Gastel et al., 1997; Pages et
al., 1997; Alexopoulos et al., 1999), comorbid personality disorder (Van Gastel et al.,
1997), comorbid alcohol dependence or abuse (Cornelius et al., 1995; Pages et al., 1997),
comorbid anxiety disorder (Schaffer et al., 2000), female gender (Pages et al., 1997,
Schaffer et al., 2000), age (Lynch et al., 1999), unemployment (Pages et al., 1997), life
events (Monroe et al., 2001), poor social support (Alexopoulos et al., 1999), hopelessness
(Rudd, 1990, Van Gastel et al., 1997, Pages et al., 1997) and previous suicide attempts
(Alexopoulos et al., 1999) as risk factors for suicidal ideation in MDD. (Table 2).
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2.8.3 Risk factors for suicide attempts in MDD
Numerous studies on non-fatal suicidal behavior among depressed patients have largely
focused on risk factors of suicide attempts. Those found to be important in several
independent studies include a suicide attempt in the past (Avery & Winokur, 1978; Corbitt
et al., 1996), or in the family (Paykel et al., 1975; Crook et al., 1975; Linkowski et
al., 1985; Roy, 1993b; Malone et al., 1995), high severity or early onset of depression
(Bulik et al., 1990; Roy, 1993b; Malone et al., 2000), comorbid personality disorder
(Paykel & Dienelt, 1971; Friedman et al., 1983; Fyer et al., 1988; Corbitt et al., 1996;
Van Gastel et al., 1997; Soloff et al., 2000), comorbid alcohol dependence or abuse (Bulik
et al., 1990; Duggan et al.; 1991, Roy, 1993b), comorbid chronic physical illness (Duggan
et al., 1991), younger age (Van Gastel et al., 1997; Castrogiovanni et al., 1998), marital
isolation or discord (Crook et al., 1975; Bulik et al., 1990; Roy, 1993b), recent adverse
life events (Paykel et al., 1975; Van Gastel et al., 1997), hopelessness (Rifai et al.,
1994; Malone et al., 2000; Soloff et al., 2000) and, not unexpectedly, suicidal ideation
(Bulik et al., 1990; Malone et al., 1995; 2000). However, it remains controversial whether
or not comorbid anxiety disorders do, in fact, increase (Lepine et al., 1993) risk of a
suicide attempt (Noyes, 1991; Friedman et al., 1992; Allgulander, 1994; Placidi et al.,
2000). (Table 2).
2.8.4 Risk factors for completed suicide in MDD
The lifetime risk of a non-fatal suicide attempt among patients with MDD is estimated at
about 40% (Malone et al., 1995), and may be an important proxy outcome in the
investigation of risk factors for suicide. In their review Harris & Barraclough (1998)
calculated that the combined causes of death-risk for all affective disorders were 1.7
times greater than expected. Every sixth death among individuals with affective disorder
treated as psychiatric patients is caused by suicide (Lönnqvist, 2000). However, the often
quoted rate of 15% of completed suicide among psychiatric patients with severe depressive
disorders (Guze & Robbins, 1970) has lately been debated and reassessed. Blair-West et al.
(1999) reported a combined lifetime suicide risk in major depression patients of 3.4% (7%
for males and 1% for females) and Bostwick & Pankratz (2000) reported subsequently a
lifetime risk of 8.6%.
In several earlier studies, as risk factors for completed suicide in MDD have been
identified to include among others: a history of previous suicide attempts (Fawcett et
al., 1987, Nordström et al., 1995; Angst et al., 2005; Coryell & Young, 2005), male sex
(Modestin & Kopp, 1988; Höyer et al., 2004), previous psychiatric hospitalizations
(Modestin & Kopp, 1988; Höyer et al., 2004; Coryell & Young, 2005), hopelessness (Fawcett
et al., 1987; Coryell & Young, 2005), suicidal ideation (Fawcett et al., 1987; Coryell &
Young, 2005), comorbid substance use disorder (Fawcett et al., 1987; Dumais et al. 2005),
comorbid personality disorder (especially Cluster B) (Hansen et al., 2003; Dumais et al.
2005), anxiety (Fawcett et al., 1987) and increasing age (Höyer et al., 2004). (Table 2).
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2.8.5 Hopelessness and its relation to suicidal behaviour and MDD
Since the 1970’s Beck and colleagues among others have shown in their reports that
hopelessness contributes to the relationship between depression and suicidal behaviour.
They also introduced a special scale for measuring hopelessness. Cognitive research on
suicide and risk prediction has developed a model of suicidal behaviour in which
hopelessness is a key psychological variable. Hopelessness as it occurs in depressed
patients, may be viewed as having characteristics pertaining to both state and trait.
During depression, hopelessness escalates and then subsides over the course of illness
(Beck et al., 1975; 1990; Beck & Weishaar, 1990; Beck, 2005; Williams et al., 2005a).
2.8.6 Limitations of earlier studies
While studies often provide important insights into the risk factors of non-fatal forms of
suicidal behaviour during depression, they also tend to have important limitations that
compromise the generalizeability, or even at times the validity of the findings. With few
exceptions (Duggan et al., 1991; Bronisch & Hecht, 1992; Nordström et al., 1995;
Alexopoulos et al., 1999; Lynch et al., 1999; Oquendo et al., 2002; Hansen et al., 2003),
most of the available studies are cross-sectional, and are based on selected patient
populations. Moreover, suicide attempters are often compared with non-attempters who may
also have high levels of suicidal ideation. If ideation and attempts are assumed to share
common risk factors, such a design feature weakens the study’s ability to recognize risk
factors. Several studies have been conducted exclusively within inpatient settings (Avery
& Winokur, 1978; Linkowski et al., 1985; Malone et al., 1995; 2000; Corbitt et al., 1996;
Van Gastel et al., 1997; Pages et al., 1997; Alexopoulos et al., 1999; Soloff et al.,
2000), or only outpatients (Monroe et al., 2001), or exclusively geriatric patients (Rifai
et al., 1994; Alexopoulos et al., 1999; Lynch et al., 1999), have had small sample sizes
(Slater & Depue, 1981; Bulik et al., 1990; Duggan et al., 1991; Roy et al., 1993b;
Bronisch & Wittchen, 1994; Rifai et al, 1994; Malone et al., 1995; 2000; Lynch et al.,
1999; Soloff et al., 2000; Monroe etal., 2001), or been retrospective (Avery & Winokur,
1978; Schaffer et al., 2000) or have investigated populations with diagnostically mixed
affective disorders (Fawcett et al., 1990; Nordström et al., 1995). Thus the
generalizeability of their findings to other settings or populations, or their power to
detect risk factors, may have been limited.
Van Gastel et al. investigated the risk factors common to both suicidal ideation and
attempted suicide (Van Gastel et al., 1997). Furthermore, suicidal ideation has often been
measured with only a single item from a depression symptom scale, such as HAM-D or BDI
(Alexopoulos et al., 1999; Schaffer et al., 2000; Monroe et al., 2001). In fact, very few
studies can claim to both have a representative utilized patient sample and rigorous
methodology. Moreover, since the etiology of suicidal behaviour is known to be
multifactorial (Mann, 1999), a broader range of explanatory variables, in addition to mere
symptom measures, is desirable. For example, social support may protect against suicidal
acts by providing a reason for living (Malone et al., 2000), even among deeply depressed
patients.
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3 AIMS OF THE STUDY
This  study  investigated the risk  factors of suicidal  behaviour (suicidal ideation and suicide
attempts) both cross-sectionally and prospectively, short-term course of suicidal ideation,
treatments received, attitudes of and adherence to treatment of suicidal
patients in a sample of 269 MDD patients.
The specific aims of the study were:
  1. To examine the risk factors of suicidal ideation and suicide attempts, and to
        highlight any difference between the two, in a sample of MDD patients effectively
        representing psychiatric in- and outpatients in the city of Vantaa in Finland.
  2. To investigate prospectively the risk factors of attempted suicide among
        psychiatric out- and inpatients with major depressive disorder (MDD) in the city of
        Vantaa, Finland.
  3. To investigate prospectively the short-term course of suicidal ideation and the
        temporal relationship between suicidal ideation and depressive symptoms, level of
        hopelessness and level of anxiety symptoms among psychiatric patients with MDD.
  4. To investigate treatment received and self-reported attitudes as well as
        adherence to treatment by comparing patients with or without suicidal ideation or
        attempts at baseline.
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Figure 4. Flow-chart of the sampling procedure in the VDS
        Screening                           Negative
                                            (no current MDD)
        N = 806                             N = 103
        Screen Positive                     Not consenting
                                            (refused)
        N = 703                             N = 161
        Consenting                          No current MDD
        N = 542                             N = 273
                                            At the end of the
                                            18-month follow-up
        DSM-IV MDD                          Dead N = 8
        N = 269                             Switched to bipolar N = 13
                                            Drop out N = 50
        6-month follow up                   SSI   6                      Refused to participate in
        N = 218                             N = 103                      the weekly follow-up
                                                                         N = 33
        18-month follow up                  Weekly follow-up
        N = 198                             N = 70
DSM-IV  =  Diagnostic and Statistical Manual of Mental Disorders, 4th edition
MDD     =  Major Depressive Disorder
SSI     =  Scale for Suicidal Ideation
                          ≥
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4 MATERIALS AND METHODS
4.1 General study design
The VDS is a collaborative depression research and development project conducted between
the Department of Mental Health and Alcohol Research of the National Public Health
Institute, Helsinki, and the Department of Psychiatry of HUCH, Peijas hospital (the Peijas
Medical Care District PMCD), Vantaa, Finland. The catchment area comprises the city of
Vantaa (population 169 000 in 1997). The Department of Psychiatry at Peijas hospital
offers secondary care psychiatric services to all Vantaa citizens. These include a
psychiatric inpatient unit, a general hospital outpatient clinic, four community mental
health care centres – each covering a specified catchment area – and two day hospitals.
4.2 Screening
The first phase of patient sampling for the VDS Cohort Study involved screening all
patients in the PMCD for a possible new episode of DSM-IV MDD between February 1, 1997
and May 31, 1998. During that period, all patients (N=806) aged 20-59 years, who were 1)
seeking treatment at, 2) being referred to or 3) already receiving care and currently
showing signs of deteriorating clinical state in the Department of Psychiatry, but without
a clinical diagnosis of ICD-10 schizophrenia or bipolar I disorder, were screened for the
presence of depressive symptoms. The screening instrument included the five screening
questions regarding depression from the WHO Schedule for Clinical Assessment in
Neuropsychiatry (SCAN), version 2.0 (Wing et al., 1990). The Scale for Suicidal Ideation
(SSI) (Beck et al., 1979) was also completed in order to disclose the individuals with
moderate to severe suicidal ideation or plans. If the following criteria matched the
patients after either 1) a positive response to any of the SCAN screening questions, 2)
clinical suspicion of depression by the interviewing personnel, or 3) a score of six or
more (≥6) in the SSI irrespective of any depressive symptoms, he/she was fully informed
about the study project and his/her participation requested. Of the 703 eligible patients,
161 (22.9%) declined to participate, but 542 (77.1%) agreed and gave their written
informed consent. The non-participating did not differ significantly (p>0.05) in age or
gender from those who consented. The Ethics Committee of Peijas Hospital approved the
study on December 2nd 1996. (Figure 4).
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4.3 Baseline evaluation
4.3.1 Diagnostic measures
In the second phase of sampling, the 542 consenting patients were interviewed face-to-
face by a researcher using the WHO SCAN, version 2.0, for which all had received training
by a WHO certified training centre. Patients were examined whether or not the current mood
episode fulfilled the criteria for (unipolar) DSM-IV MDD. All psychiatric and medical
records in the PMCD, including a standardized set of laboratory tests, were also available
at the interview. Patients with current alcohol or other substance abuse were interviewed
after two or three weeks of abstinence, in order to eliminate substance-induced mood
disorders. On this basis, 269 of the 542 patients participating in the second phase of
sampling were diagnosed with DSM-IV MDD and were included in the study. Diagnostic
reliability was verified using 20 videotaped diagnostic interviews; the kappa coefficient
for MDD was 0.86[0.58-1.0], with 95% observed agreement rate.
The decision to include the patient in the study cohort was made by the researcher during
the interview, after which an entire SCAN interview was conducted to achieve a full
picture of Axis I comorbid disorders. In addition, the Structured Clinical Interview for
DSM-III-R personality Disorders (SCID-II) (Spitzer et al., 1989) was also used to assess
diagnoses on Axis II.
4.3.2 Exclusion criteria
Patients with a diagnosis of DSM-IV bipolar I or II disorder, schizoaffective disorder,
schizophrenia or another nonaffective psychosis, organic or substance-induced mood
disorder, were excluded from the study, even if they fulfilled the symptom criteria of
current MDE. Also excluded were the cases with a history of MDD if the current episode did
not fulfil the criteria of the disorder.
4.3.3 Observer and self-report scales
In the cohort baseline measurements the following observer scales were used: the 17-item
Hamilton Depression Rating Scale (HAM-D) (Hamilton, 1960) was used to assess the severity
of depression, the Scale for Suicidal Ideation (SSI) for the severity of the suicidal
ideation, the Social and Occupational Functioning Assessment Scale of DSM-IV (SOFAS)
(Goldman et al., 1992) for the level of functioning.
The self-report scales used in the study included the 21-item Beck Depression Inventory
(BDI) (Beck et al., 1961) for the severity of depression, Beck Anxiety Inventory (BAI)
(Beck, 1988) for the level of anxiety, Beck Hopelessness Scale (HS) (Beck et al., 1974)
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for the level of hopelessness, Interview for Recent Life Events (IRLE) (Paykel, 1983) for
life events and Perceived Social Support Scale-Revised (PSSS-R) (Blumenthal et al., 1987)
for the level of social support.
4.3.4 Suicidal behaviour
Suicidal behaviour was investigated in several ways. Current suicidal ideation was first
examined using the Scale for Suicidal Ideation (SSI). SSI is a 19-item observer scale
designed to quantify the intensity of current conscious suicide ideation in various
dimensions of self-destructive thoughts or wishes: the extent of the wish to die, the
desire to make an actual suicide attempt and details of any plans; also internal
deterrents to an active attempt, and subjective feelings of control and/or "courage"
regarding a proposed attempt. Each item consists of three alternative statements graded in
intensity from 0 to 2, with the maximum total score being 38. Here suicidal ideation
refers to patients who scored ≥6 in the SSI (Beck & Kovacs, 1979). Secondly, the
interviewer asked the patient whether they seriously considered suicide at any point
during the current major depressive episode.
In addition, the occurrence of a suicide attempt during the current major depressive
episode was investigated, based on both the interview and psychiatric records. By
definition, a suicide attempt had to involve at least some degree of intent to die;
self-harm with no suicidal intention was not classified as a suicide attempt.
4.3.5 Adequacy of treatment received
During the acute phase of the index episode, the majority of patients (78%) were receiving
antidepressants at normal adult doses (Melartin et al., 2005). The adequacy of
antidepressant dosage was defined as usual adult doses recommended in the APA Practice
Guideline (American Psychiatric Association, 2000). Psychotherapeutic support comprised of
regular appointments with a mental health professional with the aim to help the patient by
discussing his or her own problems. The patients whose diagnosis switched to bipolar
disorder during the follow-up (13/269, [5%]) were excluded from the analyses. The outcome
of MDD and the comorbid disorders were investigated at 6-month follow-up by repeated SCAN,
version 2.0 and SCID-II interviews, the observer- and self-report scales and medical and
psychiatric records.
4.3.6 Attitudes toward treatment
Attitudes toward antidepressant and psychotherapeutic treatment were assessed separately
through interviews and rated on a Likert scale according to the following items: patient
(1) actively wants treatment, (2) passively accepts treatment, (3) has reservations about
treatment, (4) has definite negative attitudes toward treatment, (5) could not answer. At
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the 6-month follow-up, patients were interviewed with scales according to the following
items: attitudes toward treatment are (1) very positive, (2) positive, (3) neutral, (4)
negative, (5) very negative, or (6) could not answer (Melartin et al., 2005).
4.4 Follow-up procedure
4.4.1 Outcome measures and life-chart methodology
Of the 269 subjects with current MDD initially included in the study, 198 were still alive
at the end of the 18-month follow-up period, had remained unipolar and could be followed
up (Melartin et al., 2004). The patients whose diagnosis switched to bipolar disorder
during the follow-up (13/269, [5%]) were analysed separately.
The outcome of MDD and the comorbid disorders were investigated at 6 and 18 months by
repeating SCAN, version 2.0 and SCID-II interviews, the observer- and self-report scales
and medical and psychiatric records.
A detailed life chart was created with the duration after the baseline divided into three
classes: a) state of full remission (0 of the 9 criteria symptoms for major depressive
episode), b) partial remission (1-4/9 symptoms), and c) major depressive episode (5+/9
symptoms).
Two alternative definitions for duration of the index episode were used: the uninterrupted
duration of the episode of major depressive episode-1) time with full MDE criteria, and
time to the first onset of state of full remission that lasted at least two consecutive
months-2) time to full remission (Melartin et al., 2004).
4.4.2 Suicide attempts during the follow-up period
Occurrence of a suicide attempt before the baseline interview and during the follow-up
period was based on both the interview and the psychiatric records (Study II). By
definition, a suicide attempt had to involve at least some degree of the intent to die;
self-harm with no suicidal intention was not included. Patient months were calculated
based on the life chart. Information on the deaths among all the 269 patients during the
follow-up period was obtained from the official records from the Statistics of Finland.
For the validity of the results, it is essential to verify that there were no more
suicidal patients among those dropping out than among those followed up. This did not seem
to be the case. Patients who could not be not followed up did not differ significantly
from the patients who were, in terms of suicide attempts before the index episode (18% vs.
14%), suicide attempt during the index episode (25% vs. 23%), or suicidal ideation (38%
47
vs. 39%). However, they were somewhat younger, were more often living alone, had a higher
score on the EPI-neuroticism scale, and more often had a comorbid dysthymia (Melartin et
al., 2004).
4.4.3 Weekly follow-up of suicidal ideation and covariates
A comprehensive evaluation of patients’ suicidality was conducted on a weekly basis until
suicidal ideation was resolved. Seventy of the 103 patients with current suicidal ideation
at the baseline were followed up weekly, and the SSI, HS, BAI, and BDI scores were
measured (Study III). We initially planned that the weekly observation would be
discontinued once the patient received two consecutive zero scores in the SSI. However,
this goal was perhaps overly optimistic, and thus, we subsequently decided to analyze the
weekly observations after the first score of zero in the SSI. All patients were followed
up from the baseline to at least two observations, with the maximum follow-up time being
26 weeks. For 47 patients suicidal ideation was resolved, 8 patients dropped out, and 15
patients were followed up for the maximum period.
Patients who could be followed up successfully, as compared with those who were not,
had higher level of psychopathology, more anxiety disorders (46[66%] vs. 13[39%],
χ2=6.349, df=1, p=0.018), more cluster B personality disorders (19[27%] vs. 2[6%], χ2=6.141,
df=1, p=0.017), higher level of hopelessness (12.6±4.7 vs. 10.5±4.8, F=4.083, df=1, p=0.046).
4.4.4 Prospective follow-up of treatment attitudes and adherence
The first 6-month-period of the follow-up and the treatment of the index episode of the
MDD were prospectively in focus when the attitudes and adherence of the patient were
examined (Study IV). Of the 269 patients with current MDD initially included in the study,
218 were followed up and had remained unipolar at the 6-month follow-up.
Patients who could not be followed up did not differ from the patients who were followed
up in terms of gender, patient status at the baseline (out- or inpatient), attitudes
toward antidepressive medication or psychotherapy, prevalence of anxiety disorders,
alcohol dependency/abuse, overall personality disorders, cluster A or C personality
disorder, suicidal behaviour, the level of depression, hopelessness, functioning or
suicidal ideation at the baseline. However, they were younger (34.6±9.7 years vs.
40.8±11.0 years, F=13.541, df=1, p<.001 ANOVA), more often married or co-habiting
[33/51(65%) vs. 101/218(46%), χ2=5.582, df=1, p=0.02], had more often cluster B personality
disorder [12/51(24%) vs. 27/218(12%), χ2=4.141, p=0.049], perceived less social support
[PSSS-R score 35.8±12.3 vs. 39.8±12.8, F=4.099, df=1, p=0.044 ANOVA] and they received
less antidepressive medication at the baseline [17/48(35%) vs. 189/218(87%), χ2=59.220,
df=1, p<.001].
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4.4.5 Self-reported treatment adherence
Self-reported adherence concerning the provided treatments was investigated by
interviewing patients at the 6-month follow-up using a Likert scale with the following
response items: the patient has come to sessions/been on antidepressant treatment (1)
regularly, treatment compliance adequate with respect to treatment goals, (2) somewhat
irregularly and it is unclear whether this would affect treatment goals, (3) very
irregularly, the treatment did not proceed according to plan, (4) not at all, the
treatment could not be implemented (Melartin et al., 2005).
4.4.6 Statistical analyses
The t-test, chi square-test with Yates’ continuity correction, Fisher’s exact test,
ANOVA, and the Kruskal-Wallis test were used in all four studies.
In the first study the statistical methods included non-parametric and parametric analyses.
Post hoc subgroup differences were compared by using the Tukey HSD method. Multivariate
nominal regression models were created, classifying suicidal behavior as the dependent
variable into three mutually exclusive categories: non-suicidal patients (the reference
group), suicidal ideators without suicide attempts, and suicide attempters. A variety of
predetermined independent variables were included. Age and different rating scale scores
were treated as continuous variables in all analyses unless otherwise mentioned. Variables
not significantly associated with the independent variable in the multivariate nominal
regression model were omitted from the final analysis. In order to avoid circularity, the
suicidality items of the depression rating scales were omitted in nominal regression
models, and the analysis were verified with and without these items.
In the second study, logistic regression models were created, classifying suicide attempt
during the follow up as the dependent variable. The statistical methods also included the
Mann-Whitney test to compare continuous variables not normally distributed.
In the third study, the decline of suicidal ideation was studied during the follow up with
survival methods by defining the outcome as the first time when two consecutive zero
measurements for SSI were found. The overall decline was displayed with the Kaplan-Meier
survival curve. Cox’s proportional hazard models with time-varying covariates were used
to study the impact of reaching threshold levels in hopelessness, depression or anxiety
scores prior to the decline of suicidal ideation while adjusting for the initial scores of
suicidal ideation. For each measure, the appropriate threshold level was defined
separately. The time-varying covariates representing the decline in hopelessness,
depression or anxiety scores, were given the value ’one’ if the corresponding threshold
level (BDI<10, BAI<10, HS<9) was reached for the first time, and ’zero’ before that.
Sensitivity of the results was investigated by varying the chosen threshold values.
Altered threshold values did not change the findings. The plausibility of the proportional
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hazards assumption was checked by plotting the logarithms of the cumulative baseline
hazards against the follow up time in appropriate comparison groups, as well as with
residual analyses of the models. Since the data was collected mostly from outpatients,
there were some missed appointments and therefore, missing weekly measurements. The
proportions of missing values were on average 32% for SSI, 21% for HS, 20% for BAI and
30% for BDI. Therefore, a more robust measure than the weekly scores of the covariates
was needed in the analyses of decline.
In the fourth study, patients’ attitudes and adherence to treatment at the baseline and at
6-month follow-up between the different groups of suicidal behaviour were compared.
Suicidal behaviour was classified according three mutually exclusive categories:
non-suicidal patients (the reference group), suicidal ideators without suicide attempts
and suicide attempters, based on the suicidal behaviour manifesting at the baseline
interview or preceding the index episode. To adjust for confounding differences in
severity of major depression and other characteristics, such as gender, age, marital
status, HS score, BAI score, alcohol dependency or abuse, PSSS-R score, SOFAS score and
personality disorder (any, cluster A, B, or C), multinominal regression models were
created. In these models, suicidal behaviour was set as the dependent variable, and
possible confounding factors as well as attitudes and adherence to treatment served as
independent factors. All non-significant factors were removed from the final analysis.
SPSS software, versions 9.0, 11.0 or 12.0.1 (SPSS Inc. 1989-2005), and Stata software
(StataCorp LP) were used .
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5 RESULTS
5.1 Suicidal ideation and attempts in MDD (Study I)
5.1.1 Clinical and demographic characteristics of the sample
The characteristics of MDD patients without suicidal behaviour, and with suicidal ideation
or suicide attempts, are presented in Table 3. Significant differences were found between
the three groups in the degree of depression and suicidal ideation; prevalence of
psychotic features, alcohol dependence or abuse, cluster B personality disorder, the
degree of anxiety, hopelessness, social and occupational functioning and perceived social
support. Furthermore, in post hoc subgroup comparisons, suicidal ideators were found to
have a significantly higher level of depression (HAM-D, p=0.005; BDI, p=0.001) and
hopelessness (p<0.001), a lower level of perceived social support (p<0.001) and
functioning (p=0.004), they were more often males (p=0.02) and had alcohol dependence or
abuse (p=0.01) more than the non-suicidal subjects. In addition, suicide attempters had a
higher degree of depression (HAM-D, p<0.001) and anxiety (p<0.001), lower level of
functioning (p<0.001) and more alcohol dependence or abuse (p<0.001) than the suicidal
ideators.
5.1.2 Suicidal ideation and attempts during the current episode
58% of the patients reported suicidal ideation during the current episode, males more
often than females (69 % vs. 54%; χ2=5.109, df=1, p=0.02). During the current depressive
episode 15% of the patients had attempted suicide (13 % of males vs. 16 % of females;
χ2=0.572, df=1, p=0.449).
Among the 269 depressed patients 158 (59%) had some suicidal behavior. Suicidal ideation
according to the SSI (score ≥ 6) was current in 103 patients (38%), while 144 (54%)
reported suicidal ideation at some point during the current episode. Of the 41 (15%)
patients who had attempted suicide, only two (5%) had done so without suicidal ideation at
any stage of the current depressive episode (Figure 5).
5.1.3 Risk factors for suicidal ideation or suicide attempt
The nominal regression models predicting various types of suicidal behavior are presented
in Table 4. The factors most strongly associated with suicidal ideation were high levels
of hopelessness, alcohol dependence or abuse, low levels of functioning and poor perceived
social support. Suicide attempt was associated with severity of MDD, alcohol dependence or
abuse, younger age and low level of functioning.
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Table 3. Characteristics of patients with MDD according to suicidal behaviors.
                 Non-suicidal        Suicidal            Suicide      Total      
                                     Ideation            Attempters  
                 N (%)               N (%)               N (%)       N (%)    
Overall          111  (41)           117  (44)           41   (15)           269  (100)
Sex
   Malesa        22   (20)            41  (35)            9   (22)            72  (27)
   Females       89   (80)            76  (65)           32   (78)           197  (73)
Age, mean ± sd   40.5 ± 11.4         39.4 ± 11.1         37.8 ± 10.0         39.6 ± 11.05
Psychotic
depressionb       4   (4)            11   (9)             7   (17)           22   (8)
HAM-D score,
mean ± sdc       17.5 ± 5.1          19.8 ± 6.0          24.0 ± 5.2          19.5 ± 5.9
SSI score,
mean ± sdd        0.5 ± 1.2           9.0 ± 7.6          15.0 ± 8.9           6.4 ± 8.1
BDI score,
mean ± sde       25.4 ± 8.3          29.4 ± 7.9          29.1 ± 10.0         27.7 ± 8.6
BAI score,
mean ± sdf       20.2 ± 10.4         22.6 ± 10.3         27.5 ± 10.5         22.4 ± 10.6
HS score,
mean ± sdg        8.9 ± 4.3          11.3 ± 4.9          11.0 ± 4.8          10.3 ± 4.8
Alcohol
dependence/      13   (12)           32   (27)           21   (51)           66   (25)
abuseh
Personality
disorder         40   (36)           56   (48)           22   (54)           118  (44)
  Cluster A      16   (14)           28   (24)            7   (17)           51   (19)
  Cluster Bi      9   (8)            18   (15)           12   (29)           39   (15)
  Cluster C      27   (24)           40   (34)           18   (44)           85   (32)
Anxiety
disorder         61   (55)           61   (52)           30   (73)           152  (57)
Smokingj         42   (38)           48   (41)           25   (61)           115  (43)
SOFAS score,
mean ± sdk       55.2 ± 9.7          50.8 ± 10.5         45.5 ± 11.8         51.8 ± 10.9
PSSS-R score,
mean ± sdl       42.8 ± 11.2         36.3 ± 13.1         36.9 ± 13.4         39.1 ± 12.7
a χ2 = 7.306, df = 2, p= 0.026
b χ2 = 7.646, df = 2, p= 0.022
c    HAM-D = Hamilton Depression Rating Scale, F= 21.67, p< 0.001, ANOVA
d    SSI = Scale for Suicidal Ideation, χ2 =119.13 , df= 2, p< 0.001, Kruskal Wallis test
e    BDI = Beck Depression Inventory, F= 6.912, p = 0.001, ANOVA
f    BAI = Beck Anxiety Inventory, F= 7.4, p= 0.006, ANOVA
g    HS = Beck Hopelessness Scale, F= 7.920, p< 0.001, ANOVA
h χ2 = 26,126, df = 2, p< 0.001
i χ2 = 10.946, df = 2, p = 0.004
j χ2 = 6.801, df = 2, p = 0.03
k    SOFAS = Social and Occupational Functioning Assessment Scale, F= 14.006, p<0.001 , ANOVA
l    PSSS-R = Perceived Social Support Scale-Revised, F= 8.429, p< 0.001 , ANOVA
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Table 4. Nominal Regression Models for Different Suicidal Behaviours.
                 Non-suicidal   Suicidal Ideation              Suicide Attempt
Variable         OR             OR    95% CI    Wald    p     OR    95% CI    Wald    p    
Male sex         (1.0)          1.52  0.76-3.04  1.421   0.23  1.34  0.47-3.87  0.300   0.58
Age              (1.0)          0.98  0.95-1.00  3.208   0.07  0.96  0.92-1.00  3.789   0.052
HAM-D score      (1.0)          1.05  0.99-1.11  2.571   0.10  1.16  1.06-1.27  10.880  0.001
HS score         (1.0)          1.08  1.01-1.15  5.149   0.02  1.06  0.97-1.16  1.471   0.23
Alcohol
dependence/abuse (1.0)          2.19  1.01-4.74  4.010   0.04  6.29  2.40-16.41 14.097  0.001
PSSS-R score     (1.0)          0.97  0.95-1.00  4.369   0.04  0.97  0.93-1.00  2.698   0.10
SOFAS score      (1.0)          0.96  0.93-0.99  7.398   0.007 0.94  0.90-0.98  8.653   0.003
OR       Odds Ratio
HAM-D    Hamilton Depression Rating Scale
HS       Beck Hopelessness Scale
PSSS-R   Perceived Social Support Scale-Revised
SOFAS    Social and Occupational Functioning Assessment Scale
Figure 5. Suicidal behavior among depressed patients (N = 269)
a
b d
c
a  Patients with suicidal ideation (156/269)
b  Patients, who attempted suicide with suicidal ideation (39/269)
c  Patients, who attempted suicide without suicidal ideation (2/269)
d  Depressed patients without suicidal behavior (111/269)
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5.2 Risk factors for attempted suicide in MDD (Study II)
5.2.1 Suicide attempts during the prospective follow-up
During  the  18-month  prospective  follow-up,  8%  of  the patients reported at least one, and
altogether 41 discrete suicide attempts. The risk of a suicide attempt during full
remission was 4/1201 patient months, during partial remission 12/1441 months (relative
risk 2.50), and during MDE 25/995 months (relative risk 7.54, χ2=24.3, df=2, p<0.001). Of
all the 269 patients in the cohort, eight patients (3%) died during the 18 months after
the baseline, three (1%) of them through suicide.
5.2.2 Differences between suicide attempters and non-attempters
Significant differences were found between the attempters and non-attempters (Table 5) in
terms of severity of index episode depression, the degree of suicidal ideation and
anxiety, the prevalence of personality disorder, prevalence of suicide attempts during the
index episode, time to full remission and total time spent in MDE, and marital status
(lack of partner). Patients with cluster B or borderline personality disorder had more
attempts (Mann-Whitney test, Z=-2.146, p=0.032 and Z=-2.165, p=0.030 respectively).
5.2.3 Predictors of suicide attempt during the follow-up
In the logistic regression model predicting suicide attempts during the follow-up period
(Table 6), the predetermined covariates comprised gender, age, marital status, HAM-D
score, alcohol dependence or abuse, BAI score, personality disorder (any), cluster B
personality disorder, suicide attempt during the index episode, and time spent in MDEs
(months). After removing the non-significant variables, three factors were strongly
associated with suicide attempt: months spent in MDEs (OR 1.13), suicide attempt during
the index episode (OR 5.62) and lack of partner (OR 5.10).
5.2.4 Patients who switched to bipolar disorder
Patients who switched to bipolar disorder (5%) were a particularly suicidal subgroup. They
reported more suicidal ideation before the index episode (69% vs. 38%; Fisher’s exact
test, p=0.039), had more suicide attempts before the index episode (62% vs. 22%; Fisher’s
exact test, p=0.003) and non-significantly during the follow-up (22% vs. 8%; Fisher’s
exact test , p=0.17).
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Table 5. Differences in Characteristics Between Those Who Did and Did Not Attempt 
Suicide of the 198 Patients with Unipolar MDD during the 18-month Prospective Follow up.
Characteristic No SA           SA           All Patients    p   
Total N (%)                               182  (92)       16   (8)     198  (100)
Sociodemographic features
Sex, N (%)
     Male                                  51  (28)        4   (25)     55  (28)
     Female                               131  (72)       12   (78)    143  (72)
Married or co-habitinga                   104  (57)      3   (19)    107  (54)       .004
Age (years), mean ± sd                    41.2 ± 11.0     38.4 ± 11.3  41.0 ± 11.1
PSSS-R score, mean ± sd                   39.4 ± 12.8     35.2 ± 14.4  39.0 ± 13.0
Depression related characteristics
Severity of depression at baselineb                                                    .02
     Mild                                  11  (6)         -   -        11  (6)
     Moderate                              99  (54)        4   (25)    103  (52)
     Severe                                72  (40)       12   (75)     84  (42)
Psychotic features, N(%)                   11  (6)         2   (13)     13   (7)
Melancholic features, N(%)                 67  (37)        7   (44)     74   (37)
Time to full remission
(months), mean ± sdc                      4.0 ± 4.7       8.1 ± 7.5    4.4 ± 5.1       .002
Total time in MDEs
(months), mean ± sdd                      4.4 ± 4.7       8.6 ± 7.1    4.8 ± 5.0       .002
Symptom scores 
HAM-D score, mean ± sde                   18.6 ± 5.9      23.8 ± 6.0   19.1 ± 6.1      .001
SSI score, mean ± sdf                     5.5 ± 7.3       12.6 ± 10.7  6.1 ± 7.8       .008
BDI score, mean ± sdg                     27.0 ± 8.1      31.1 ± 7.7   27.4 ± 10.8     .057
BAI score, mean ± sdh                     21.2 ± 10.6     27.4 ± 11.0  21.7 ± 10.8     .026
HS score, mean ± sd                       10.0 ± 4.7      11.4 ± 4.0   10.1 ± 4.7
SOFAS score, mean ± sd                    52.7 ± 10.2     48.3 ± 12.6  52.3 ± 10.4
History of suicidal behavior
SA during the index episode, N(%)i         21  (11)         7  (44)     28  (14)       .003
SA before the index episode, N(%)          42  (23)         4  (25)     46  (23)
SA before/ during the index episode, N(%)j  55  (30)         9  (56)     64  (32)       .049
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Characteristic No SA           SA           All Patients    p   
Psychiatric comorbidity
Psychiatric comorbidity (any), N(%)       141  (78)        13  (81)    154  (78)
Alcohol dependence/abuse, N(%)             40  (22)         4  (25)     44  (22)
Alcohol dependence, N(%)                   21  (12)         2  (13)     23  (12)
Alcohol abuse, N(%)                        19  (10)         2  (13)     21  (11)
Personality disorder (any), N(%)k          74  (41)        11  (69)     85  (43)       .036
     Cluster A                             32  (18)         5  (31)     37  (19)
     Cluster B                             24  (13)         4  (25)     28  (14)
     Cluster C                             54  (30)         8  (50)     62  (31)
     BPD                                   20  (11)         3  (20)     23  (12)
Anxiety disorder (any), N(%)               98  (54)        10  (63)    108  (54)
     Panic disorder                        22  (12)         4  (25)     26  (13)
     Agoraphobia without panic             20  (11)         2  (13)     22  (11)
     Social phobia                         30  (17)         4  (25)     34  (17)
     Simple phobia                         43  (24)         7  (44)     50  (25)
     GAD                                   23  (13)         3  (19)     26  (13)
     OCD                                    9  (5)          -  -         9   (4)
     PTSD                                   2  (1)          -  -         2   (1)
a      Fisher’s exact test.
b χ2= 7.764, df=2.
c      F= 9.427, df=1, ANOVA.
d      F= 10.367, df=1, ANOVA.
e      F= 11.228, df=1, ANOVA.
f χ2= 6.943, df=1, Kruskal-Wallis test.
g      F= 3.665, df=1, ANOVA.
h      F= 5.038, df=1, ANOVA.
I      Fisher’s exact test.
j      Fisher’s exact test.
k      Fisher’s exact test.
Abbreviations: ANOVA = analysis of variance, BAI = Beck Anxiety Inventory, BDI = Beck Depression Inventory, BPD = borderline personality disorder,
GAD = generalized anxiety disorder, HAM-D = Hamilton rating scale for Depression, HS = Beck Hopelessness scale, MDE = major depressive episode,
MDD = major depressive disorder, OCD = obsessive-compulsive disorder, PSSS-R = Perceived Social Support Scale-Revised, PTSD = posttraumatic stress disorder,
SA = suicide attempt, SOFAS = Social and Occupational Functioning Assessment Scale, SSI = Scale for Suicidal Ideation .
Table 6. Logistic regression model for suicide attempts during the 18-month follow up. 
(N=198).
Variable                                  OR 95% CI    Wald χ2 p
Female sex                                1.39  0.36-5.28   0.228      0.63
Age (years)                               0.97  0.92-1.03   1.136      0.29
Total  time in MDE (months)               1.13  1.03-1.26   6.960      0.008
Marital  status (lack of partner)         5.10  1.32-19.71  5.589      0.01
SA  in  the baseline                      5.62  1.69-18.61  7.968      0.005
Abbreviations: MDE- Major Depressive episode, SA- Suicide Attempt
56
5.3 Duration and trends of suicidal ideation and depression
during the follow-up period (Study III)
5.3.1 Course of suicidal ideation
Suicidal  ideation   resolved   in   two  thirds  (67%)   of  the  patients,  but  persisted  for  the
entire follow-up in one fifth (21%). In addition, 11% of the patients dropped out. 50% of
the population reached zero in 2.2 months (9.6 weeks). The median time for reaching a zero
level in the suicidal ideation was 1.6 months (6.8 weeks). For patients with both the
weekly follow-up (duration of suicidal ideation) and the life chart (time with full MDE
criteria and time to full remission) measures available (n=53), the median time for the
decline to zero was 2.7 months, the median time with full MDD criteria was 2.6 months and
the median time to achieve full remission was 4.2 months, respectively. The difference in
the median time for suicidal ideation decline was not statistically significant between
patients with cluster B personality disorders and those without (1.7 months [7.4 weeks] vs.
1.6 months [6.7 weeks], p=0.45, log rank test) (Figure 6).
5.3.2 Baseline factors predicting duration of suicidal ideation
Cox’s proportional hazard models with time-varying covariates were used to study the
effect of risk factors predicting the duration of suicidal ideation. A high baseline level
of suicidal ideation, depressive symptoms, and the presence of any personality disorder
each predicted a longer duration for suicidal ideation.
5.3.3 Predictors for a decline in suicidal ideation
In separate analyses, a decline in hopelessness, depressive symptoms and anxiety were each
significant predictors for the decline in suicidal ideation. In all analyses, adjusting
for the initial level of suicidal ideation showed that the decline depends significantly
on the severity of the baseline symptoms; the higher the initial level, the longer the
duration. The importance of the initial level of suicidal ideation was stable in all
separate analyses.
When analysing the impact of a decline in hopelessness, depressive symptoms and anxiety
symptoms jointly in the decline of suicidal ideation, the apparent separate effect of
anxiety turned out to be non-significant (Table 7), whereas declines in both depression and
hopelessness had independent effects on the decline in suicidal ideation. This may be due
to the high correlation between subsequent scores in hopelessness and anxiety (0.8). Since
the decline in hopelessness was more rapid in anxiety, it apparently masked the effect of
the decline in anxiety.
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Table 7. Cox proportional hazard models for the decline of suicidal ideation adjusted separately 
for the normalization of depressive symptoms (BDI), anxiety (BAI), and hopelessness (HS) and 
jointly for all.
                                           Separate models              Joint model
               Depression                  Anxiety           Hopelessness     
Variable       HR   95% CI        p        HR   95% CI        p        HR   95% CI        p        HR   95% CI        p 
SSI baseline   0.91 0.84-0.97     .008     0.92 0.86-0.99     .023     0.92 0.86-0.97     .02      0.90  0.84-0.97     .004
BDI            7.68 3.73-15.85    <.001                                                            5.74  2.69-12.25    <.001
BAI                                        4.70 1.99-11.09    <.001                                1.62  0.59-4.48     .34
HS                                                                     5.90 2.24-15.52    <.001    3.51  1.15-10.73    .03
Abbreviations: SSI = Scale for Suicide Ideation, BDI = Beck Depression Inventory, BAI = Beck Anxiety Inventory,
HS = Beck Hopelessness Scale, HR= Hazard Ratio.
Figure 6. Decline in proportion of cases with suicidal ideation by the Kaplan-Meier 
survival curve.
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5.4 Adequacy, attitudes and adherence to treatments (Study IV)
5.4.1 Differences between clinical characteristics and treatment
Patients  with  suicidal  behaviour  had a higher level of overall psychopathology on entering
the study. Their level of depression, anxiety, hopelessness and suicidal ideation were all
significantly higher. They had also a higher prevalence of alcohol dependency/abuse,
cluster B personality disorders and any comorbidity overall. The prevalence of MDD, the
level of depressive symptoms, anxiety and suicidal ideation of patients with suicidal
behaviour remained higher at follow-up.
Suicidal patients received significantly more often antidepressant and anxiolytic
treatment, they visited their psychiatrist significantly more often and the number of
overall visits was also greater than non-suicidal patients. (Table 8). Patients with
suicidal behaviour appeared to receive treatment to correspond to their condition.
5.4.2 Attitudes and self-reported adherence to treatment
Patients with suicidal behaviour had a more favourable attitude to antidepressant
treatment both at the baseline and at the 6-month follow-up. There were no statistically
significant differences in the attitudes toward psychotherapeutic treatment. After
adjusting for the confounding effect of the level of depression and other possible
factors, the positive attitudes toward antidepressant treatment remained still
significantly associated with both kinds of suicidal behaviour. However, despite the more
positive attitudes, self reported adherence to antidepressant and psychotherapeutic
treatment did not differ between the groups (Table 9).
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Table 8. Treatment during the six-months follow-up.
NS               SI               SA               Total    
 N      (%)       N      (%) N      (%)       N      (%)    
Overall                                     92     (42)      92     (42)      34     (16)      218    (100)
Antidepressant  medicationa                 70     (76)      87     (95)      32     (94)      189    (87)
ECT                                          1     (1)        2     (2)        2     (7)         5    (3)
Anxiolytics or hypnoticsb                   33     (41)      40     (46)      23     (72)       96    (48)
Psychotherapy                                7     (8)       11     (12)       6     (18)       24    (11)
Psychosocial  support                       83     (90)      79     (88)      28     (82)      190    (88)
Visits to psychiatrist, mean ± sdc          2.7 ± 2.5        4.8 ± 4.6        6.4 ±  7.2       4.1 ± 4.5
Number of all visits, mean ± sdd            16.5 ± 14.9      25.8 ± 25.3      20.6 ± 16.7      21.3 ± 20.9
Abbreviations: NS= non-suicidal, SI = suicidal ideation, SA = suicide attempt, ECT= electro convulsive therapy.
a χ2 = 15.542, df = 2, p < .001.
b χ2 = 8.997, df = 2, p = .011.
c    F = 9.010, df=2, p < .001, ANOVA.
d    F = 4.122, df=2, p = .018, ANOVA.
Table 9. Patients’ attitudes and self-reported adherence to treatment after 
six-month follow-up classified by suicidal behaviour at baseline.
NS               SI               SA               Total    
 N      (%)       N      (%) N      (%)       N      (%)    
Overall                                     92     (42)      92     (42)      34     (16)      218    (100)
Positive attitudes towards
     Psychotherapeutic                      80     (89)      74     (82)      27     (82)      181    (85)
     treatment at baseline
     Psychotherapeutic                      90     (98)      92     (100)     33     (97)      215    (99)
     treatment at six months
     AD treatment at bla                    39     (43)      70     (76)      26     (77)      135    (62)
     AD treatment at six monthsb            61     (68)      74     (80)      27     (82)      162    (75)
     Anxiolytics/Hypnoticsc                 32     (38)      33     (38)      20     (65)       85    (42)
Good adherence to psychotherapeutic         60     (74)      59     (67)      20     (69)      139    (70)
treatment
Good adherence to AD treatment              56     (69)      63     (71)      21     (70)      140    (70)
Abbreviations: NS= non-suicidal, SI = suicidal ideation, SA = suicide attempt, AD = Antidepressive medication.
a χ2 = 24.975, df = 2, p < .001.
b χ2 = 9.951, df = 4, p = .04.
c χ2 = 8.751, df = 4, p < .068.
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6  DISCUSSION
6.1 Main findings
Among psychiatric in- and outpatients with DSM-IV major depressive disorder, patients with
suicidal ideation or suicide attempts clearly had a higher level of overall
psychopathology. 58 % of the patients reported suicidal ideation during the current
episode and 15% had attempted suicide at the baseline. Suicidal ideation was prevalent in
almost all (95%) of the 15% of patients who had attempted suicide. The risk factors for
suicidal ideation and attempts appeared largely to overlap.
During the 18-month prospective follow up, 8% of the patients with MDD attempted suicide.
The risk of an attempt was almost eight-fold during a major depressive episode compared
with a period of full remission. Suicide attempt during the follow-up period was
effectively predicted by three independent factors: lack of a partner, history of previous
suicide attempts and time spent in major depressive episodes. Effective treatment of
depression is a credible preventive measure for suicide attempts.
Suicidal ideation resolved in the majority of the suicidal MDD patients during the first 2
to 3 months. The duration of suicidal ideation was longer for patients with a higher level
of psychopathology, such as initially high level of suicidal ideation or depressive
symptoms at the baseline, or some personality disorder. Independent declines both in
depression and hopelessness predicted the ensuing decline in suicidal ideation, and they
both could have a causal role in the reversal of the suicidal process.
Patients with suicidal behaviour often received more antidepressants, had more frequent
appointments with attending psychiatrists and received greater psychotherapeutic support
from other mental health professionals than non-suicidal patients. Suicidal patients also
had more favourable attitudes towards antidepressant treatment, and comparable adherence
to treatment than those not suicidal.
Problems in the adequacy of treatment or attitudes or adherence to treatment, were not the
factors markedly differentiating suicidal patients. Instead these problems appear to be
generic to all psychiatric care.
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6.2 Methods
6.2.1 Representativeness of the sample
The present study involved a relatively large (N=269) cohort of both out- and inpatients
with MDD, effectively representing all psychiatric patients with a new episode of MDD in
the city of Vantaa, Finland.
Two thirds of all depressed subjects in the general population of the city of Vantaa
seeking treatment from psychiatrists are treated at the PMCD (Rytsälä et al., 2001). This
study took place during the era of current antidepressants in 1997-1999 in a modern
community psychiatric setting; at the baseline, 78% of the patients received
antidepressants at adequate levels during the acute phase in compliance with the APA
Practice Guideline (Melartin et al., 2004).
6.2.2 Diagnostic measures
Patients entering the study were carefully diagnosed using semi-structured interviews with
excellent reliability (κ=0.86) for the diagnosis of MDD. However, the reliability of
comorbid disorder diagnoses remains unknown. Axis II diagnoses were assessed using the
semi-structured SCID-II interview for DSM-II-R (because in 1997 SCID-II for DSM-IV was
not available). Differences between DSM-III-R and DSM-IV were taken into account.
6.2.3 Life-chart methodology
Keller et al. (1987) introduced in the NIMH-CDS the Longitudinal Interval Follow-up
Evaluation (LIFE) methodology, first used to investigate the outcome of depression. In the
VDS the course of depression was assessed during the follow-up by using a graphic
life-chart methodology, which is a similar but not identical to LIFE. All patient records
and monthly BDI-ratings (for the first 6 months) were available. Patients’ follow-up time
was classified into periods of DSM-IV MDE, partial remission, or full remission.
6.2.4 Drop outs
The rate of total drop-outs was low, as 87% of the cases could be interviewed at least
once after the baseline. The patients whose diagnosis switched to bipolar I or II during
the follow-up period (5%) were excluded from the analyses.
However, due to deaths, diagnostic switch to bipolar disorder and dropping out after 6
months, 74% of the original 269 patients were included in the prospective follow-up study
(Study II).
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The characteristics of patients in the Vantaa Depression Study do not differ in terms of
comorbidity and symptom severity from the few other studies that have reported them
comprehensively (Zimmerman et al., 2000; Tedlow et al., 2002), supporting the
generalizeability of the findings to other settings. Factors associating with dropping out
included both postive (younger age) and negative (living alone) outcome predictors.
In Study III, 70 suicidal patients (68%) out of 103 could be followed up on weekly basis.
These patients had a higher level of psychopathology than the VDS cohort overall, or the
suicidal cases who did not participate in the weekly follow-up. It is unlikely that the
findings would have been different with patients who dropped out included. Suicidal
depressive patients commonly differ more from the non-suicidal in their subjective than
objective measures on depression. (Malone et al., 1995, van Praag & Plutchik, 1984;
Cornelius et al., 1995, Oquendo et al., 1999). In this sample there appeared to be a
similar trend.
In Study IV, it could not be determined how many of the patients who refused to
participate in the study had suicidal ideation, or attempted suicide, how they were
treated, and whether these patients differed from consenting patients with regard to their
attitudes and adherence to treatment.
6.2.5 Measurement of suicidal behaviour
The present study is among the few (Rifai et al., 1994; Malone et al., 1995; Corbitt et
al. 1996; Malone et al., 2000, Oquendo et al., 2002; 2004) to have employed a psychometric
scale (SSI) to measure current suicidal ideation. It is also one of the few to involve a
relatively large and unselected sample of both in- and outpatients with major depressive
disorder. It is quite common to use an individual item from BDI (item 9) or HAM-D (item 3)
or from some other questionnaire to investigate the prevalence or the level of suicidal
ideation. Having a psychometric scale included in the study design is far more reliable
than just a single item, which is much more vulnerable to random fluctuation. However,
suicidal ideation during the entire current MDE was explored also by direct questioning.
A predetermined cut-off point (SSI≥6) was used to define moderate to severe current
suicidal ideation. In retrospect, this may have been somewhat high (Beck et al., 1999;
Holi et al., 2005), although applying an alternative lower cut-off point (SSI≥2) did not
change our findings. In addition, although the internal consistency of SSI was high
(Cronbach’s alpha 0.85-0.90), its inter-rater reliability remains unknown.
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6.3 Results
6.3.1 Suicidal ideation and attempts among patients with MDD (Study I)
Suicidal ideation is common among psychiatric in- and outpatients with DSM-IV major
depressive disorder; nearly two thirds (58%) of the patients reported suicidal ideation at
the baseline, and suicidal ideation was prevalent in almost all (95%) of the patients
(15%) who had attempted suicide.
There were significant differences between different groups. However, the risk factors
found in the nominal regression models for suicidal ideation and attempts appeared largely
to overlap, although the overall level of psychopathology and disability among the suicide
attempters remained higher.
The role of substance use (alcohol) was probably crucial in suicide attempts. Although
cluster B personality disorders and anxiety symptoms were more prevalent among suicidal
patients compared to the whole group, neither appeared to be of major importance as an
independent risk factor.
However, the cross sectional nature of the study limited our ability to make causal
inferences, and prior to interview the temporal relationship between suicidal ideation and
suicide attempt may be complicated.
The two forms of suicidal behaviour (ideation and attempts) were associated with several
clinical variables, including severity of depression, alcohol dependence or abuse and
anxiety, which is in concordance with earlier reports. In the regression models the risk
factor domains overlapped, but were not identical. It also appeared that the impact of
alcoholism and level of depression may be greater for suicide attempts.
6.3.2 Risk factors for suicide attempt in MDD (Study II)
During the 18-month prospective follow up, 8% of the patients with MDD attempted suicide
and the risk of an attempt was almost eight-fold during a major depressive episode as
compared with a period of full remission. The risk of suicide attempt effectively was
predicted by three independent factors: lack of a partner, history of previous suicide
attempts, and time spent in major depressive episodes.
To our knowledge, this study was the first prospective investigation to employ a life
chart to place the suicide attempts, which allowed us to identify important disparities in
risk between the periods of different levels of depressive symptoms. The findings of this
study could be interpreted as evidence for the causal role of depression per se in the
aetiology of suicide attempts. However, the high level of comorbidity with anxiety,
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substance use and personality disorders in the patient population (Melartin et al., 2002),
are all factors independently related to suicidal behaviour, and thus the findings are far
from self-evident.
Despite a large cohort of patients the most important limitation of the present study was
that during the follow-up period, the number of suicide attempts was moderate and
attempters rather small.
6.3.3 Decline in suicidal ideation (Study III)
Suicidal ideation was resolved in the majority of the suicidal MDD patients during the
first two to three months. According to the original hypothesis, a decline in hopelessness
would be the main determinant for the decline of suicidal ideation. However, in the joint
analyses, declines both in depression and hopelessness independently predicted the
following decline in suicidal ideation. This finding is consistent with the interpretation
that both could have a causal role in reversal of the suicidal process. The duration of
suicidal ideation was longer for patients with a higher level of psychopathology, such as
an initially high level of suicidal ideation or depressive symptoms at the baseline, or
some personality disorder.
In this study, 70 suicidal patients (68%) out of 103 were followed up on weekly basis.
These patients had an overall higher level of psychopathology than the VDS cohort overall,
or those suicidal cases who did not participate in the weekly follow up. The duration of
decline in suicidal ideation was strongly associated with the initial level of symptoms;
the higher the initial level, the longer the duration. Personality disorders overall also
had a significant impact on the duration of suicidal ideation. Contrary to original
expectations, this was more related to overall rather than specifically, to cluster B or
borderline personality disorder.
The decline of suicidal ideation was strongly associated with the preceding decline of
depressive symptoms, level of hopelessness and anxiety. Even some decrease in the level of
depression seemed to be enough to initiate the decline in the intensity of suicidal
ideation. Suicidal ideation resolved gradually after depressive symptoms and hopelessness
have started to alleviate. The duration of ideation and the time the patients fulfilled
the criteria for a major depressive episode seemed to be similar.
Both depressive symptoms and hopelessness have a strong and consistent association with
suicidal ideation (Van Gastel et al. 1997, Pages et al. 1997, Malone et al. 2000), and
they are plausible and theoretically coherent risk factors for suicidal behaviour. The
findings of this study are consistent with earlier findings (Szanto et al. 2003, Bruce et
al. 2004) on the impact of treatment interventions to suicidal ideation among elderly
depressives.
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The findings of this study are also consistent with the interpretation that declines in
both depression and hopelessness could have a causal role in reversing the suicidal
process.
6.3.4 Adequacy, attitudes and adherence to treatments (Study IV)
In the fourth study patients with suicidal behaviour had at the baseline a higher level of
overall psychopathology, a difference that persisted during the following 6 months. In
contrast to original expectations, they received antidepressants more often, had more
frequent appointments with attending psychiatrists and received greater psychotherapeutic
support from other mental health professionals than non-suicidal patients. Suicidal
patients also had more favourable attitudes towards antidepressant treatment, and
comparable adherence to treatment than those not suicidal. However, if the severity of
depression (HAM-D score) was adjusted in the analyses, the significance was lost. Thus,
neither problems in adequacy of treatment nor attitudes or adherence to treatment were
factors markedly differentiating suicidal patients. Instead these problems appear to be
generic to all psychiatric care.
According to the results of this study, treatment appeared to be allocated rationally.
Probably due to higher severity of depression, patients with suicidal ideation or suicide
attempts more often received antidepressants, adequate antidepressant treatment and
frequent appointments with psychiatrists plus psychotherapeutic support from other
professionals than non-suicidal patients. Thus, suicidal behaviour among psychiatric
patients with MDD is not a factor that markedly influence the treatments provided.
Continuity presented a challenge in treatment here, as in psychiatric care in general.
Although most MDD patients received antidepressant treatment in the early acute phase,
about half terminated treatment prematurely (Melartin et al.,2005). Good adherence to
treatments by patients reduced the probability of relapse or recurrence of MDD (Melfi et
al., 1998). Thus, treating MDD is a central component of suicide prevention. According to
the original hypothesis, patients with suicidal behaviour would have stronger negative
attitudes and adherence to treatments than patients not exhibiting suicidal behaviour. The
issues of compliance, high attrition rate and poor adherence are well known problems from
earlier studies (Isacsson et al, 1994; Suominen et al., 1996). Unexpectedly though, in
this cohort suicidal patients had more favourable attitudes towards antidepressant
treatment than non-suicidal patients, and comparable adherence to treatment. Therefore it
seems that the patients who remain in treatment have a positive attitude, and good
adherence to treatments received.
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7  CONCLUSIONS  AND  FUTURE  IMPLICATIONS
7.1 Conclusions and clinical implications
Suicidal ideation among psychiatric patients with MDD is markedly prevalent and it appears
to be a precondition for suicide attempts. While ideation is also highly prevalent among
depressed patients attempting suicide, the risk factors for suicidal ideation and attempts
cover several clinical and psychosocial areas and largely seem to overlap. Substance use
disorders and severity of depression may be of particular importance in predicting suicide
attempts.
Suicide attempts among patients with MDD are strongly associated with the presence and
severity of depressive symptoms. The risk of an attempt during a major depressive episode
is clearly higher compared with a period of full remission. Lacking a partner, having a
history of suicidal behaviour and time spent being depressed seem to be the strongest risk
factors for future suicide attempt. Reducing time spent depressed is a highly credible
preventive measure for future suicide attempts.
The decline of suicidal ideation appears to be associated with preceding declines in
depressive symptoms and hopelessness and thus, they may have a causal relationship.
However, for patients with higher level of psychopathology, it takes longer for suicidal
ideation to alleviate.
Suicidal patients with MDD are known to have multidimensional problems, but this study
does not support the conception that patients with suicidal behaviour had more negative
attitudes or non-adherence to treatments than non-suicidal patients. These problems seem
to be common to all psychiatric care patients with MDD.
It is likely that better recognition of suicidal behaviour (both ideation and attempts)
and its risk factors among depressive patients will improve the outcome.
Psychiatric in- and outpatients with MDD have a high level of comorbidity with anxiety,
substance use and personality disorder, all of which independently implicate elevated risk
for suicide attempts. Nevertheless, risk for suicide attempt is almost eightfold during a
major depressive episode compared with an episode of full remission. As suicide attempts
are temporally associated with the presence of depressive symptoms, reducing the duration
of the depressed state would be an effective measure for the prevention of suicidal acts.
The duration of suicidal ideation approximately corresponds the time the patients fulfil
the criteria for a major depressive episode. Thus, even some decrease in the level of
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depression seems to be enough to initiate the decline in the intensity of suicidal
ideation. Effective treatment of MDD will have a positive impact on the decline of
hopelessness and thus probably in reversing suicidal ideation.
Suicidal patients with MDD are at higher risk of completed suicide and thus, they should
receive more intensive treatment. For the purpose of preventing suicide it is important
that neither suicidal ideation nor suicide attempt seem to be associated with more
negative attitudes or non-adherence to treatments.
7.2 Implications for future research
Although research on suicidal behaviour has long traditions, it focuses mainly on suicide
attempts and completed suicides. Prospective studies focusing on suicidal ideation in MDD,
and the use of a psychometric scale for measuring suicidal ideation, are still quite rare.
More prospective long-term studies are needed. Such studies would help us understand
better the course and nature of suicidal behaviour and possible comorbid factors in MDD.
We need studies focusing on the short-term course of suicidal ideation in special
subgroups, such as cluster B personality disorders.
Earlier long-term studies have focused, among others, on the association between suicidal
ideation and hopelessness with suicide attempts or completed suicides. While major
depressive disorder is a heterogenous and comorbid disorder, those patients known to be
suicidal, are at higher risk of completed suicide and should thus receive more intensive
treatment. More research is needed to investigate the effectiveness of treatments for
depression in reversing the suicidal process among adult patients with MDD.
Finally, problems concerning continuity, attitudes and adherence to treatments among
patients with suicidal behaviour and MDD need more elucidation.
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